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Foreword
Public Health Intelligence (PHI) is the epidemiology group of the Ministry of Health. PHI carries 
out the Ministry’s statutory responsibility to monitor the health of the New Zealand population 
by analysing population health outcomes and risks and determinants, and examining 
inequalities across regional boundaries and between population groups. An important role for 
PHI is the delivery and dissemination of epidemiology evidence for the development of policy 
and decision-making in the health sector.
How to Monitor for Population Health Outcomes presents guidance to public and population 
health programme managers, and interested others, on how to develop indicators to monitor 
progress on achieving population health outcomes sought from their programmes. This 
guideline has been designed to complement the information and guidance presented in the 
Ministry’s Guide to Developing Public Health Programmes: A generic programme logic model 
(Ministry of Health 2006). The need to develop a robust outcomes monitoring framework is 
driven by an increased expectation from central government that there will be a focus on results 
in the design and delivery of publicly funded services. This expectation is highlighted by the 
requirements of the Public Finance Act 2004 and the Crown Entities Act 20041 (The Treasury and 
State Services Commission 2007a; b). 
We welcome your comments and suggestions about the contents, and any additions or 
clarifications you might have.
Barry Borman
Manager (Epidemiologist)
Public Health Intelligence
1  Crown entities includes District Health Boards.
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Part A: Introducton
Key Ponts
• This How to aims to help public and population health programme managers to develop 
timely, appropriate and cost-effective outcome measures for programmes funded by 
government.
• Measuring programme performance is essential for maintaining and enhancing support 
for public health programmes.
• The process of developing a logic model and an outcomes monitoring framework is 
intended to facilitate a process of ‘continuous programme improvement’.  
• This How to should be read in conjunction with A Guide to Developing Public Health 
Programmes: A generic programme logic model (Ministry of Health 2006).
How to use ths gude
This How to aims to provide guidance to public and population health programme managers 
and planners – whether they be in District Health Boards, non-governmental organisations or 
government departments – on how to select timely, appropriate and cost-effective outcome 
measures for public health programmes. 
Throughout this How to we aim to provide plain English advice, checklists and examples to 
guide you through the process of selecting which outcomes to measure and how they should 
be measured. We provide information about some issues that are likely to arise from adopting a 
more rigorous outcomes-focused framework to monitoring public health programmes. We also 
outline the types of data held by the Ministry of Health that may be freely used to help monitor 
the performance of your public health programmes.  
The guide is structured into five parts.
• Part A: Introducton outlines the purpose of this document and where it fits in relation to 
other Public Health Intelligence (PHI) publications.
• Part B: What Objectves and Assocated Outcomes Need to be Montored? describes a 
process for translating policy goals and objectives into measurable outcome statements, and 
a process for selecting and prioritising the outcomes to be monitored.
• Part C: Issues to Consder n Outcomes Montorng discusses a number of key issues arising 
from the application of an outcomes monitoring approach to publicly funded programmes 
and small populations.
• Part D:  Avalable Data and Informaton from Publc Health Intellgence introduces PHIOnline, 
a free public access internet-based service to a wide range of government statistics that may 
be useful in monitoring a population health programme.
• A Glossary provides an alphabetical list of terms, definitions and explanatory text relating to 
outcomes monitoring language. 
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This How to builds on the material presented in A Guide to Developing Public Health 
Programmes: A generic programme logic model  (Ministry of Health 2006). The Guide provides 
a general introduction on how to design and implement comprehensive and measurable 
public health programmes in New Zealand, and includes some material on designing outcome 
measures (Ministry of Health 2006). This How to significantly expands on that material, and 
material presented at a PHI analytical workshop on Monitoring Public Health Outcomes held in 
October 2006. Ideally the Guide should be read before this How to.
The  Ministry of Health’s Leading for Outcomes website http://www.leadingforoutcomes.org.nz/ is 
another Ministry-led initiative that promotes and uses an outcomes framework to improve how 
we think about and improve health in New Zealand, starting with cardiovascular disease (CVD) 
and diabetes. The website sets out a model of risk factor and disease progression, an outcomes 
hierarchy and an indicators framework for measuring progress towards achieving better CVD and 
diabetes health outcomes in New Zealand, with a view to extension of the approach to other 
health and disability areas.
Why measure performance?
The main motivation for introducing management tools such as programme logic models, 
outcomes monitoring and managing for results is an increased expectation from central 
government that the design and delivery of publicly funded services will have a strong results 
focus. This expectation is highlighted by the requirements of the Public Finance Act 2004 and 
the Crown Entities Act 20042 and associated guidance documents (The Treasury and State 
Services Commission 2007a; b) for the development of statements of intent by departments and 
Crown agencies.  
To sum up, measuring performance:
• facilitates change and improvement
• is a mechanism for accountability
• supports planning and decision-making relating to resources
• can highlight areas requiring further work.
Ideally, performance measures for public health programmes should provide information about:
• a change in health status and health determinants achieved in priority population groups, 
including changes in inequalities
• resource and service utilisation
• the programme’s responsiveness to the target population.
2  Crown entities includes District Health Boards.
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Part B: What Objectves and Assocated Outcomes 
Need to be Montored?
Key Ponts
1. It is not always possible to monitor every objective and outcome, so you will need to 
establish a list of prioritised objectives/outcomes for monitoring. 
2. The process of planning an outcomes monitoring framework begins with translating policy 
goals and objectives into SMART objectives:
• Specific
• Measurable
• Achievable (sometimes ‘Accurate’ or ‘Action-oriented’ are used)
• Relevant (sometimes ‘Realistic’ is used)
• Time-based.
3. Management and instrument criteria can be used to assess whether it is possible and 
essential to monitor the objective or outcome of interest.  Management selection criteria are:
• attribution (accountability)
• centrality
• cost-benefit
• robustness to withstand public scrutiny
• timing.
       Instrument selection criteria are:
• availability 
• reliability
• sensitivity 
• validity.
4. Planning for outcomes monitoring requires decisions about:
• What information is required? What is the data going to be used for?
• What data is already available? Is new data really needed?
• Who is going to collect the data? 
• What type of measurement instrument could or should be used?
• How many measurement instruments are to be used?
• Who is going to do the analysis?
• When is the data required by to inform timely decision-making?
5. Table 4 provides a checklist and scorecard to help prioritise which objectives and outcomes 
are essential to monitor.
6. See the Glossary for a full list of terms and associated definitions used throughout this  
How to, and extra explanatory comment and examples illustrating the use of the terms.
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Introducton: outcomes montorng programmes
Establishing which outcomes need to be – and can be – successfully monitored requires careful 
thought and planning. Preparing an outcomes monitoring plan will help you to establish a 
successful monitoring programme. 
An outcomes monitoring plan is a process for the routine systematic collection and recording of 
timely information about aspects of a programme to assess whether progress is being made on 
achieving the programme’s objectives, and how the programme could be improved. Information 
is timely when it contains data directly relevant to the programme and – importantly – is 
available in a timeframe where it can usefully inform decisions about whether the programme is 
performing as planned, and what things need to be changed to improve the performance of the 
programme if required. 
Collecting baseline data at the start of a programme is vital to be able to assess what change 
has occurred over time, particularly when you are trying to attribute a change to an effect of the 
intervention. 
In preparing the outcomes monitoring plan you will need to assess:
• what needs to be measured to demonstrate success
• how things should be measured and by whom (deciding what indicators are going to be used, 
after considering issues such as validity, reliability, sensitivity, attribution, availability of 
suitable instruments, cost-benefit)
• the timeframes for delivering information about the performance of the programme against 
the stated objectives to decision-makers and key stakeholders
• whether a formal evaluation process is required.
A good outcomes monitoring process:
• identifies and prioritises the outcomes that are essential to monitor and that can be 
monitored appropriately
• provides timely information to key decision-makers and stakeholders about the progress 
made on achieving the desired outcomes
• uses outcome measures robust enough to withstand public scrutiny
• is cost effective
• includes baseline data relevant to the intervention.
What should you measure to demonstrate the success of the 
programme?
Critical to any successful outcomes monitoring plan is to identify what could and should be 
measured in order to show that the programme is being implemented as planned, and that 
progress is being made to achieve the desired health outcome(s). The steps involved are:
1. identify what could be measured 
2. prioritise these into those that should be measured if resources allow
3. identify the essential few that must be monitored.  
 How to Monitor for Population Health Outcomes: Guidelines for developing a monitoring framework
Underpinning this approach is the assumption that it is not always feasible – or necessary – to 
measure everything. 
The first place to look to determine what could and should be monitored is to identify what the 
key programme objectives, outcomes and outputs are. You should be able to identify these from 
the ‘logic model’ developed for the programme. A logic model is a planning tool that describes 
the purpose, what, where, when, and how of the programme being implemented. 
Ideally, programme objectives, outcomes and outputs should be clearly distinguished from each 
other (see Table 1 for definitions of these terms) and expressed in action words. Expressing 
outcomes statements clearly makes it easier to identify what actions need to be undertaken, 
what changes need to take place, what the desired end result is, and consequently what needs 
to be monitored. 
Table 1: Dstngushng objectves, outcomes and outputs3 
Objectves are statements about the results a programme seeks to achieve. Any programme 
must have at least one objective.
Objectives may form a hierarchy that moves from a limited set of high-order objectives that 
are synonymous with aims or goals to be achieved in the long term (five to seven years). 
Underneath high-level objectives are more intermediate-level objectives that are to be 
achieved in a three- to five-year time frame, and which must be achieved in order to attain the 
high-level objective. The lowest levels of objectives are immediate or operational objectives 
that must be achieved first – typically in one or two years.    
Objectives may be translated directly into ‘outcomes’ if they deal with only one issue. 
However, double-barrelled objectives will require multiple outcome measures to be 
developed.
Outcomes are specific statements about the intended change in public health-related 
attitudes, knowledge, behaviours, or physical health status in the target population(s) sought 
by undertaking the planned public health activity.  In some situations ‘process’ outcomes may 
be desirable. 
Process outcomes typically measure the amount of effort put into a programme and the 
quality of the service provided. They can also be appropriate where it is important to monitor 
community support for a programme.  Process outcomes that measure effort can be expressed 
as ‘outputs’.
Outputs are things (such as goods) produced, services delivered, events held, or participation 
generated resulting from the activities undertaken. 
3  See the Glossary for a full list of other terms and associated definitions used throughout this How to, and extra 
explanatory comment and examples illustrating the use of the terms.
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What makes good outcome statements that are measurable?
Have you used acton words n actve statements?
In some cases, even though a programme’s objectives and outcomes can be identified, they 
may be stated in a way that makes them difficult to measure or unsuitable for programme 
planning or contracting purposes.  This can happen because the language used is too passive 
in tone, or is too complex or abstract. Consequently, in some situations it may be necessary to 
translate the identified objectives into language that is more suitable for monitoring. Ensuring 
the language used is active rather than passive will help to do this.  
Active statements involve ‘action’ words, and a list of action words identified as suitable for 
public health is provided in Table 2. 
Table 2: Lst of acton words for wrtng performance objectves
Accept Adopt Advocate Analyse Arrange
Approve Appraise Bargain Calculate Care
Change Choose Classify Categorise Challenge
Chart Compare Conduct Construct Contrast
Co-operate Check Defend Define Demonstrate
Describe Develop Differentiate Discriminate Draw
Evaluate Execute Explain Express Fill out
Forecast Formulate Generate Identify Inform
Instal Interview Judge Justify Label
List Locate Manipulate Modify Name
Operate Organise Outline Persuade Plan
Prepare Prescribe Produce Purchase Question
Rank Recall Recognise Reflect Remove
Research Resolve Review Select Sort
Specify State Study Take Tell
Translate Use Write
Source: Bartholomew et al 2006
Take, for example, the following objective:
 Communication plans will be developed to ensure stakeholders are kept informed.
This sentence contains the idea of what needs to be done, but responsibility for doing it and 
therefore an emphasis on the action needed is lost because of the passive form. Compare this 
with the alternative wording, using an active form and action words:
 The committee will develop communication plans to ensure stakeholders are kept informed.
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Using a bullet list for objectives lets you start each objective with an action word, which can be a 
forceful way of conveying the objectives; for example:
 The committee will:
• develop communication plans to ensure stakeholders are kept informed
• prepare a report on the nutrition in schools open day
• inform parents about the progress their children have made. 
Are they SMART objectves and/or outcomes?
Another good approach to identifying which objectives and/or outcomes are able to be 
measured, or to reconfigure them so that they are measurable, is to ask yourself, are they SMART 
objectives (Iverson 2003)?  SMART objectives/outcomes are defined in Table 3. 
Table 3: Definng SMART objectves
Item Definition
Specific An objective should address a specific target or accomplishment.  Specific implies that 
an observable action, behaviour or achievement is described, which is also typically 
linked to an identifiable change in rate, number, percentage or frequency. 
Measurable A method should be established to indicate that an objective has been met. That is, 
there should be a system, method or procedure for tracking and recording the change in 
behaviour or action towards which the objective is directed. 
Achievable* Though not necessarily easy or simple, the objective should be feasible – that is, 
capable of being achieved.  Objectives should be limited to what can realistically be 
done with available resources, and ideally the resulting change should be ‘attributable’ 
to the action undertaken.  
Relevant* An objective should be significant to the people involved in the programme (from 
beneficiaries to the programme’s sponsoring organisation), and the objectives should 
be capable of having an impact or making a change. 
Time-based An objective should be achievable within a specific timeframe. Generally this takes the 
form of a start and end date. The time may be short (two or three months, up to two 
years), medium (three to five years), or long term (five years to seven years).
Source: Iverson A. 2003. Preparing Program Objectives: Theory and Practice. The International Development Research 
Centre: Evaluation Unit, Toronto
*  What A and R stand for is inconsistent in the literature. A is sometimes given as ‘accurate’, ‘action-oriented’, 
‘accountable’ or ‘attributable’. R is sometimes given as ‘relevant’ or ‘realistic’. In some situations, these alternative 
phrases may be more useful, in which case use the term that is most appropriate or that most clearly helps to describe 
the intent of the objective.
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Montorng double-barrelled objectves
Double-barrelled objectives contain multiple components, and if well written have the 
advantage of being able to convey multiple objectives in one single sentence rather than using 
several sentences. However, they are also more complex to monitor. Using the above criteria, 
we need to ask the question: Are double-barrelled objectives SMART? Here are two examples of 
double-barrelled objectives.
• Objective 1: Enable people with chronic conditions to improve their health, slow progress of 
their condition(s), and maintain independence wherever possible by aligning community and 
hospital services across [  ] DHB.
• Objective 2: Reduce the incidence of cancer, diabetes, and cardiovascular disease by 20% 
over the next five years.
The first objective has multiple components in that it refers to chronic conditions, and talks 
about slowing the progress of the conditions, maintaining independence and aligning services. 
It could be argued that this objective, as written, is a good high-level objective in that it uses 
some action words that provide an overall  general direction for the DHB, and it complies 
adequately with the SMART criteria in Table 3 in terms of a high level objective statement. 
However, for operational and monitoring purposes it is does not adequately comply because  
it does not specify the chronic conditions, time frame and services. All of these issues would 
have to be addressed when developing the logic model and outcomes monitoring plan to 
achieve this high-order objective. Multiple outcome measures would have to be used to assess 
whether this objective was achieved, because different measures would need to be used for 
each component.  
The second objective also has multiple components, but it clearly specifies the chronic 
conditions of interest, the size of change sought, and the timeframe for achieving the changes. 
The objective complies with the criteria in Table 3, although the objective would also require 
the use of multiple outcome measures – a different measure for each chronic condition – for 
progress on its achievement to be monitored appropriately. 
In answer to the question, are double-barrelled objectives SMART? the best advice is generally 
to avoid double-barrelled objectives when writing low-order (ie, operational) objectives. This will 
make planning clearer and the objectives easier to monitor. Where double-barrelled objectives 
may be desirable (eg, when writing high-level objectives), make sure they comply as closely 
as possible with the criteria in Table 3. Also, remember that where double-barrelled objectives 
are used, multiple outcome measures will generally have to be developed to monitor each 
component of the objective statement. 
Prortsng objectves/outcomes for measurement 
After identifying and clarifying the range of objectives and/or outcomes that could be monitored 
in an ideal world, it is highly likely that it will not be feasible – or necessary – to monitor all the 
objectives and outcomes planned for. Consequently, a process of prioritisation will have to take 
place to select the objectives and outcomes that are both essential and possible to monitor.  
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We suggest two types of criterion to use as aids in making decisions about which outcomes 
should be and can be monitored: 
• management considerations 
• instrument selection considerations. 
Management considerations are concerned with promoting the development of an appropriate 
and robust monitoring system. Instrument selection considerations are concerned with 
establishing scientific credibility for the monitoring system. Figure 1 illustrates how these 
two types of criterion relate to each other. They are also further discussed in the following 
pages. Although the criteria can be defined separately, in practice they are interrelated and a 
judgement will have to be made as to where the balance lies between the merits of each.
Fgure 1: A framework for prortsng what outcomes to montor
By examining each objective and indicator using the criteria set out below, you will be able to 
develop a prioritised selection of the outcomes and associated indicators that can and should 
be measured appropriately. To help with this, it may be useful to use a scorecard such as that 
provided in Table 4. The scorecard provides a method for rating each outcome and indicator 
against the criteria. Note that more than one indicator can be used to monitor an outcome, but it 
may not be necessary or cost effective to do so. 
The scorecard is simple to use: just assign a ‘1’ score to each criterion that has been 
successfully met. All the scores are added up, and the outcomes and associated indicators with 
the highest score should receive the highest priority for inclusion in the outcomes monitoring 
plan. A slightly more complex approach, which would provide better differentiation between 
possible indicators, would be to use a scoring approach that allows for decimal points; for 
example, instead of scores of 1 or 2, a score of 1.5 could be allocated.  In some situations a 
more sophisticated approach may be desirable, in which case a ‘weighted’ system could be 
applied to the scorecard. In a ‘weighted’ approach, some criteria would be judged as more 
or less important than others, and consequently a higher or lower range of possible scores 
could be allocated to the selected criteria.  For example, because of the size and nature of the 
programme it may be decided that the instrument selection criteria of validity and reliability are 
so important that they are worth double points compared to the others (ie, the results are going 
to be weighted (biased) towards indicators that score well on those factors). 
Management criteria
for selecting outcomes
that should be
monitored:
• attribution
   (accountability)
• centrality
• cost–benefit
• robustness to
   withstand scrutiny
• timing.
Instrument selection
criteria for selecting
outcomes that can be
monitored robustly:
• availability
• reliability
• sensitivity
• validity.
Outcomes
prioritised
for
monitoring
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Management selecton crtera for prortsng what s essental to 
montor n publc health programmes
Attrbuton (accountablty)
Attribution is the extent to which change in the outcome of interest is associated with the type of 
activity undertaken. Attribution is an important issue to consider because it has implications for 
how well a programme’s activities can be said to have resulted in any changes observed, and for 
assigning the level of accountability for the success or failure of a programme or its components.
Strong attribution requires being able to establish a clear and unambiguous causal link between 
what you do and what happens – something that is often problematic for many public health 
programmes. When assigning attribution, you need to beware of any ‘attributional bias’ that 
results from over-attributing a change to any particular activity. 
Centralty
How important is the outcome of interest to establishing the success of the programme? The 
more central the outcome, the more important it is to measure it appropriately. Where data is 
not available, think carefully about developing a new measure, or using an appropriate ‘proxy’ 
measurement (see ‘Availability’ below).
Whether a programme is deemed successful or not is not always related to whether the central 
health outcome of interest has been achieved. A programme may fail in one aspect but still be 
successful if other outcomes of importance have been achieved.
Cost–benefit
‘Cost–benefit’ refers to the balance between the cost of using and/or developing a measure 
and the benefit that will be gained from implementing it. For many programmes, you will need 
to make a judgement about whether the cost of developing a monitoring regime or measure is 
worth the benefit to be gained from the information provided. Where the cost outweighs the 
benefit, then consider using an appropriate proxy indicator, or information from a pre-existing 
monitoring regime. 
In general, the proportion of the total budget spent on monitoring should be in the region of  
5% to 20%, depending on the type and size of the programme. If the programme is a pilot 
initiative, the results of which could be used to significantly influence whether the programme 
is expanded into a major effort, then 20% of the total budget could be appropriate. If the 
programme has a large budget and is well established, applied in standard ways and supported 
by evidence for its effectiveness, then a budget allocation of 5% may be more appropriate for 
monitoring purposes.  
Cost per output is probably the best method to use when calculating the cost of a monitoring 
programme or a component of it.  For example, the cost of purchasing information from 
an existing data set may be cheaper than doing it yourself.  Or, it may be cheaper to use a 
proxy measure than to use a direct measure (assuming the proxy measure is robust enough 
to withstand public scrutiny and the information trade-off is acceptable). Note that cost 
effectiveness is just one of a number of criteria that should be used in planning an outcomes 
monitoring regime. 
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Robustness to wthstand scrutny
Robustness will be provided by ensuring that the instrument selection criteria (presented 
below) are observed. Be very clear about why a particular set of outcomes has been selected for 
monitoring and not others, and why particular measurement instruments have been selected 
over others. Ask yourself the following. 
• What is being monitored? 
• Why and how is it going to help to assess the effectiveness or efficiency of the programme as 
a whole?
• Why is it essential?
• When must the information be available? 
• How is the data to be collected? 
• Who is going to do the collection and analysis? 
• Is the proposed approach cost effective? 
• Will the information be provided in a timely manner? 
• Will the monitoring system withstand scrutiny by stakeholders?
For public health programmes funded by government money, it is important that assessments 
of the effectiveness of the programme be able to withstand public scrutiny. In this context, 
we suggest it is usually advisable not to attribute a programme’s success to a single criterion: 
robustness is provided by the strength of logic of the total outcomes monitoring regime. 
Tmng
Timing has two aspects to it. The first concerns establishing ‘attribution’ (see above). In this 
case, timing refers to establishing the time sequence between when an activity took place and 
when a change in the desired outcome was observed. The second aspect relates to being able 
to report to stakeholders on the performance of a programme in a timely manner, which also 
means the proposed indicator must be able to be produced within an appropriate timeframe.
As a general rule, the timeframe for short-term objectives can be as short as two to three months 
or up to two years.  The medium term is defined as three to five years, and a timeframe of five 
to seven years is usual for achieving long-term objectives (The Treasury and State Services 
Commission 2007a; b).
In practical terms, it may not be feasible to monitor/measure progress on attaining short-term, 
or even medium-term, objectives using national data. For example, information from national 
survey and administrative data sets is typically not available anywhere from 6 to 36 months after 
the data was originally collected due to data checking and quality control processes. This may 
mean that it is not feasible to use information from these data sources as indicators because the 
data is not available soon enough.
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Instrument selecton crtera for prortsng what s possble to montor 
approprately n publc health programmes
Avalablty
This refers to whether data, or a measuring instrument, already exists at the local or national 
level that could be used to help monitor the outcome of interest. Where possible, use existing 
data that may be sourced from within your organisation or a range of government agencies  
or organisations such as public health organisations in your area. A good place to start  
seeing what data is already available to help monitor your programme is at PHIOnline,  
www.phionline.moh.govt.nz, which includes data at national, District Health Board and 
Territorial Local Authority level (see Part D for an introduction to the range of information 
available to you on PHIOnline). Using existing information sources can save a considerable 
amount of time and effort. 
Where such data exists, efforts should be made to use that data or instrument rather than 
invest in developing new data sources or instruments. If issues such as cost, complexity 
and/or timeliness prevent direct measurement of the outcome of interest, consider using a 
proxy indicator. If achieving the central outcome is vital, and data is not readily available, 
careful thought needs to be given to spending extra effort on developing a new measure, or on 
identifying a suitable proxy measure.  
Relablty
Reliability is the extent to which a measure, when used repeatedly in the same way, will produce 
the same or a similar result. For example, if you were interested in monitoring a person’s weight 
and used a weighing machine that produced a different reading each time it was used (when all 
other factors were the same), then the machine would not be a reliable instrument to use.
Senstvty
Sensitivity refers to how well a measure is able to detect when a change has occurred in the 
outcome being monitored. For example, a weighing machine that was able to differentiate a 
change in weight by 100 gram graduations is more sensitive than a machine that can only detect 
changes in 500 gram amounts.  
Specificity is another criterion that is particularly appropriate in clinical settings, where it is used 
to assess how accurate a clinical test is in identifying people at risk.
Valdty 
Validity refers to how well a measurement, index or indicator reflects the outcome it is intended 
to measure. For an outcome measure to be valid, it should be both sensitive and specific.   
Often there is more than one way of measuring an outcome, and the most valid measure may 
not be practical in all situations. For example, the best way to measure body composition 
(particularly lean and fat mass) is under-water densitometry (weighing), but this is not practical 
outside small clinical studies. Therefore, measures of weight adjusted for height (eg, body mass 
index, BMI) are often used to reflect body composition, particularly body fat mass. Although 
BMI is correlated with body fat mass, this relationship varies according to body build, age and 
ethnicity. Therefore, BMI is not recommended for assessing excess body fat mass (obesity) at an 
individual level.
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However, BMI can be useful for assessing obesity at a population level if used and interpreted 
appropriately. BMI based on direct measurement of height and weight is more valid than BMI 
based on self-reported height and weight, particularly if measurements are taken by trained 
observers using appropriate equipment and standardised procedures.
Ultimately, the choice of measure for a particular programme will depend on a number of factors, 
including validity and practicality.
Table 4: Checklst and score card for prortsng outcomes and ndcators for montorng
Outcome of 
nterest
Indcator 
name
Crtera Total 
score
Prorty
At Av Ce Cb Re Rb S T V
Outcome 1
Output 1
Objective 1
Crtera abbrevatons
At  Attribution (Accountability) Av  Availability   Ce  Centrality 
Cb  Cost–benefit Re  Reliability Rb  Robustness to withstand public scrutiny
S  Sensitivity  T  Timing V  Validity
Source: Adapted from Table 1 ‘How to select indicators’ (page 68) in United Nations Development Programme Evaluation 
Office 2002
Addtonal questons and gudance for selectng outcome 
measures and ndcators 
Do you need a new outcome ndcator or nstrument? 
Think carefully before developing a new outcome indicator or instrument, ask yourself  
the following.
•  Why is a new indicator/instrument needed?
• Is it because there is a problem with an existing indicator/instrument, or is it because it really 
is a new outcome?
• Can we use existing data creatively to answer the question?
Every instrument has its own strengths, weaknesses and peculiarities – the perfect instrument 
does not exist. If you are unfamiliar with the instrument that best suits your plans, seek help 
from someone who knows about it already. Public Health Intelligence at the Ministry of Health 
have extensive expertise in measuring public health outcomes. If in doubt, seek their advice.
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Match the measurement nstrument to the objectve
Choose the level of observaton
What is the focus of interest? Is it an individual or a group of people? If it is an individual, 
perhaps the measurement is of an individual’s change in knowledge and behaviour due to the 
intervention, or maybe it involves observing a change in their health status over time.  Is the 
focus on groups of patients (eg, patients from a particular age group, with a specific disease, 
or submitted to a certain intervention), or their ability to access services? If the intervention’s 
utility or the general quality and cost-effectiveness of different care systems is the main interest, 
compare the quality of care between different systems; say, between primary and secondary 
care or between geographic locations. 
Formulate and descrbe the measure’s ams
What is your aim for the measure? Do you want to describe, compare or evaluate health 
outcomes? The selection of your instruments is highly related to the endpoints of your project.  
What do you want to use the instrument for?
The principal uses for a health measure are as follows.
• A health status measure can be used as an indicator, measuring the current health condition/
state of a person or a population group at a point in time. In addition to validity, both 
reproducibility and specificity to the chosen health condition are important. Reproducibility 
is particularly important when undertaking a robust pre- and post-assessment of change 
following the intervention. 
• A health outcomes measure can be used as a comparison, relating differences at 
different points (eg, before and after intervention). For this type of action, sensitivity and 
responsiveness to change are important. Put simply, the measure must be able to register 
small changes in people’s health.
• A health outcomes assessment implies that, apart from being an outcome measure, it 
is an attempt to use the information through feedback to the users of the information, 
including government funders of the programme. Apart from achieving the outcomes sought, 
government funders may also be interested in cost-effectiveness measures. 
• Process outcome montorng can use both qualitative and quantitative measures to report 
on process evaluation issues. This type of information helps to provide the ‘story behind 
the statistics’, and is useful for reporting on the following aspects that may be critical to the 
monitoring and success of the programme:
– community capacity
– service/agency capacity
– compliance with good practice 
– programme integrity.
Examples of these types of measure are goal attainment scaling, global assessment scales and 
other rubric-based scoring.
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Cost-effectveness measures
Cost effectiveness refers to the balance between the cost of implementing the intervention and 
the benefit or effectiveness gained from programme. There are many ways of measuring cost 
effectiveness. The three approaches suggested by (The Treasury and State Services Commission 
2007a; b) as being appropriate for Crown entities are:
• cost-benefit analyss, which is seen as the ‘gold standard’ for establishing cost effectiveness
• cost per unt of mpact/outcome, which is a simpler approach (assuming it is feasible to 
quantify the impact/outcome gained)
• cost efficency, which is a method by which the cost per output is measured. This approach 
is likely to be particularly appropriate where the service provided (eg, a public health 
information service) is remote from any health outcome.
Cost per output is probably the most useful method when calculating the cost of a monitoring 
programme or a component of it. For example, the cost of purchasing information from an 
existing data set may be cheaper than doing it yourself. Note that cost-effectiveness is just one 
of a number of criteria that should be used when planning an outcomes monitoring regime. 
Decde on the type of nstrument
It is important to note that the ‘psychometric’ qualities of the instrument you choose must be 
able to support your goals and objectives. This means it is essential that the instruments are 
valid and reliable (see above). 
• In general, a condition-specific measure will have a narrow focus but will contain considerable 
detail in the area of interest. If you are interested, say, in one disease condition, and the 
assessment is mainly of symptoms and function, then use a condition-specific measure.
• If a specific domain, such as daily functioning or mental wellbeing in different populations, is 
your interest, use a dimension-specific instrument.
• If you are interested in general health or in the interaction between different conditions, or 
if you are interested in populations that may include healthy people, then you should use 
generic instruments.
• If you think the influence of other diseases or conditions that you have not measured may 
influence the results of the problem or the disease of interest, combine disease-specific and 
generic instruments.
No one instrument will prove satisfactory for all purposes. You may need to combine instruments 
because a reasonable instrument does not exist. But beware: when possible, use the 
instruments in their original form. Do not change them or use only parts of them. Validation 
covers only the complete instruments that were tested (see above on reliability and validity). 
Be careful with instruments that are taken from one country to be used in another. Cross-cultural 
validation needs to follow strict rules. Even a survey that has been validated in Canada, the UK 
or the US may not be valid in New Zealand because of different cultural dynamics and language 
uses. The formal validation of an instrument is a costly and time-consuming process. How much 
of this work you do depends on your resources. And don’t forget the practicalities: the necessary 
time to fill in questionnaires and the costs of mailing and analysis. Think about your target 
group: for example, not every instrument suits children or older people.
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The measures selected must align with the programme’s goals and objectives.  It is therefore 
important to understand the programme’s goals and objectives so that appropriate selections 
can be made from the many measurement instruments available.  In particular, you will need to 
determine whether an intervention’s effect is to be measured or descriptively assessed.
You will need broadly validated instruments that have been used in other studies if you want the 
intervention to describe the health status of a defined population or a specific disease category. 
Short, feasible and reliable instruments are recommended if care providers are to use them in 
their clinical work.
Collectng and analysng nformaton
Selecting the right measures is only part of the process of establishing a monitoring system. 
You will also need to think about how the information will be collected and processed.  There is 
no point choosing the perfect set of measures if there is no feasible way to collect and use the 
information.
Ask the following questions.
• What is the cost of collecting the required information?
• How easy is it to access the information?  
• Are there administrative, privacy and ethical issues?
• Has the cost of data analysis been allowed for?  
• Who is going to do the analysis?
• Who is the audience for or user of the information?
It takes time and skill to correctly analyse and interpret data, and this needs to be allowed for 
when planning a monitoring regime. The amount of time to allow depends on the complexity of 
the analysis and the type of information collected. Ask the following types of questions.
• What type of analysis is required? That is, what type of questions have to be answered: 
descriptive or explanatory? (Generally, explanatory analysis will require more work than 
descriptive analysis to prepare.)
• Who is going to use the information? 
• What decisions will be made with the findings?
• When does it need to be done by?
• Who is going to do it? Do they have the skills?
In general, where the users of the information are senior decision-makers and/or the funding  
for the programme is significant, the more robust the analysis needs to be in order to  
withstand scrutiny, and consequently the more time should be allocated to this task.  
For major regional and national programmes involving the analysis of multiple indicators and  
the preparation of complex tables and report writing, a time period of several weeks or months 
is not unreasonable. 
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Part C: Issues to Consder n Outcomes 
Montorng
Key ponts
1. Outcomes monitoring is intended to help:
a. facilitate a process of  ‘continuous programme improvement’
b. build confidence in, and support for, public health programmes.
2. Outcomes monitoring is not a cheap replacement for a traditional evaluation process.
3. Outcomes monitoring may, or may not, include a traditional formative process and impact 
evaluation exercise.
4. Beware of the problem of small numbers.
Outcomes montorng as a tool for ‘contnuous programme 
mprovement’: the problem of accountablty, attrbuton and 
performance management 
The main motivation for introducing management tools such as programme logic models, 
outcomes monitoring and managing for results within the state sector is an increased 
expectation from central government that there will be a focus on results in the design and 
delivery of publicly funded services. 
This expectation is highlighted by the requirements of the Public Finance Act 2004 and the Crown 
Entities Act 20044 (The Treasury and State Services Commission 2007a; b). This legislation means 
that there is now an increased emphasis on ‘maximising results for the available resources’, 
and managers must report on the impacts, outcomes, or objectives that a programme seeks to 
achieve or contribute to, and how it will contribute to implementing government policy directions 
(The Treasury and State Services Commission 2007a; b). Increasingly, these expectations are now 
being transmitted into the services contracted for by government agencies. 
The reporting requirements in the acts include stating the:
• rationale for the main types of interventions planned and the results expected
• risks identified and how they will be managed
• main measures that will be used to monitor progress and performance – including the cost 
effectiveness of the activities
• how the programme will link to other government agency programmes to support them, 
including those activities undertaken by non-government organisations (The Treasury and 
State Services Commission 2007a; b). 
4 Crown entities includes District Health Boards.
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Implicit in this approach is the idea of ‘accountability’ for achieving the objectives set and 
outcomes sought. As a general principle, the degree to which accountability can be maintained 
depends on the ability of the person or organisation to meaningfully influence the changes 
sought. Strong accountability can only be maintained where there is a clear and unambiguous 
causal link (ie, attribution) between cause and effect. 
For many government activities, including public health programmes, establishing clear causal 
links between an intervention and change in the outcome sought – in this case population 
health – is difficult. A number of practical difficulties must be overcome (Nutbeam 1998). 
Consequently, when assigning attribution in public health programmes, you should beware 
of any ‘attributional bias’ that would result in over-attributing a change to a single programme 
activity. 
It is likely that success will not be achieved through a single activity, but by undertaking a range 
of activities and working with other programmes and across-government agencies to achieve 
the objectives. This means that using outcomes monitoring as a strict contract performance 
management tool is problematic. This does not mean that non-government organisations and 
providers of government services should not be accountable for the choice of methodology and 
quality of implementation undertaken to achieve the health objectives.
The use of logic models and outcomes monitoring should be seen as a way of instituting a 
‘continuous improvement cycle’ in the design and delivery of publicly funded programmes 
(The Treasury et al 2005), rather than as a contract performance management tool to be feared.  
With the continuous improvement approach, the performance of organisations is focused on 
their ‘understanding, reviewing, and learning from the efficiency and effectiveness of their 
operations’ (The Treasury et al 2005).  The approach provides a tool for helping programmes to 
evolve over time in response to changes in the environment and as programme objectives are 
achieved. 
This approach is a recognition that being able to attribute outcome changes to particular 
interventions or outputs ‘won’t always be feasible’ (The Treasury and State Services Commission 
2007b).  This does not absolve service providers from any responsibility and accountability 
for designing, implementing, monitoring and reporting on the effectiveness and efficiency of 
their programmes. It does mean that  where establishing attribution is difficult, it is even more 
important that a clear logic (rationale) for the intervention be stated, and that where a number 
of similar but small programmes are being implemented, all the programmes use the same 
reporting framework and attribution takes place at the group level rather than at the individual 
programme provider level. 
In terms of contract performance management, providers should be reassured that the approach 
recommended here includes considering the full range of reasons for meeting or not meeting 
a target. The important thing is that there is a robust programme planning and monitoring plan 
that will enable us to answer questions such as:
• What impact have our interventions had?
• What else was going on at the same time that also had an impact?
• Can we learn from our performance monitoring, and how can we improve in response to the 
lessons?
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Outcomes montorng versus evaluaton 
Along with the new emphasis on using logic models for planning and monitoring for health 
outcomes there has been an implicit shift towards a monitoring process that relies on 
quantitative methods using epidemiological and biostatistical methods, rather than traditional 
formative and process evaluations. This shift in emphasis should not be seen as something 
particularly new, but rather as a reflecting the ongoing evolution in public management thinking 
and practice. In this case, the use of logic models can be seen as an evolving from ‘Managing by 
Objectives’ to ‘Managing for Outcomes’. Similarly, ‘outcomes monitoring’ reflects an evolution in 
the practice of ‘evaluation’. 
• Traditional evaluation of public health programmes tended to focus on qualitative methods 
and formative and process questions, although current practice is to use multiple methods.  
• Monitoring for outcomes tends to use quantitative methodologies and focuses on endpoints. 
However, depending on what the programme is supposed to achieve, formative and process 
evaluation may still form a legitimate part of an outcome monitoring framework. For example, 
where community acceptance of a new type of intervention is critical to achieving the ultimate 
health outcome sought, then a formative and process evaluation would be appropriate.   
A full programme evaluation that includes formative, process and outcomes evaluation is likely 
to be appropriate for major national-level campaigns. Such evaluation examines long-term 
changes in health status and the determinants of health. These include changes in knowledge, 
awareness and behaviour; shifts in social, economic and environmental conditions; as well as 
changes to public policy and health infrastructure. 
Outcome or impact evaluation also seeks to measure the reduction in health status inequities 
between population subgroups. In this approach, it is important to identify and measure 
short-, medium- and long-term outcomes to ensure the ongoing support and relevance of the 
activity for those whose agendas are shorter term. Outcomes evaluation also uses indicators 
as benchmarks, or proxy measures, to assess the extent to which objectives have been met.  
Matching objectives to associated indicators in a logic model helps to ensure the availability of 
relevant data sources for programme evaluation.
Note that a monitoring regime using quantitative methodologies should not be seen as a cheap 
replacement for evaluation. Both approaches require skilled staff to advise on the most robust 
methods and measures to use and to undertake the data analysis, and both rely on robust 
administrative systems. 
The problem of small numbers
Monitoring the outcome of an intervention requires a health indicator that can, among other 
things:
• detect the outcome sought from the intervention
• be used to provide a baseline measure against which future measurements, which commence 
after the intervention has started, are compared 
• consistently be used over the time period of interest.
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The first is usually the hardest to determine, but statistical power analysis calculations and 
the explanations that form the logic behind the use of the indicator can help decide whether 
you should even begin a monitoring process using the indicator. The second is usually easy 
to determine, because it simply requires data before and after the intervention. The third is 
more difficult than it appears because it can be easy to introduce changes in the way the data 
is collected over time. Assessing whether the indicator has been consistently used requires 
someone with a good knowledge of the process.
A good health status indicator measures either:
• prevalence (the number people with the condition in the population, divided by the total 
number of people in the population), which can be expressed as a ratio;  or
• ncdence (the number of new cases of the condition in the population divided by the 
total number of people in the population) of a disease, condition or risk factor, which can 
be expressed as a ratio. Generally, incidence is for a specified period of follow-up of the 
population of concern (eg, one year).
In both measures, the numerator or population from which one identifies the cases must match 
the denominator population. 
The problem with these types of indicators in New Zealand is that either or both the numerator 
(the number of people with the health status of interest) or the denominator (the number of 
people in the population as a whole) may be very small. When the numbers are small, then 
statistically it can be difficult to measure the prevalence or incidence, and it also becomes very 
difficult to detect whether a change has occurred, let alone to decide whether any detectable 
change is related to any effect of the intervention. 
Example 1: Illustratng mortalty ncdence: New Zealand’s crude mortalty  
rate n 200
In 2006, 28,390 deaths were registered in New Zealand and, as of 30 June 2006, 4,127,000 
people were estimated to be living in New Zealand.  So the crude mortality rate is 28,390 
divided by 4,127,000, which equals 0.0069. This translates to 1 death per 145 people, or 688 
deaths per 100,000 people in the denominator population. 
This is an incidence rate. Mortality rates are always incidence rates due to the fact that there 
is no prevalent pool, because the cases are all deaths in New Zealand and so they match the 
same population as the denominator.
Detectng change n small numbers
The ability of an indicator to detect the effect of an intervention depends on a combination of 
factors, including:
1. senstvty (the ability to pick up accurately a change in the outcome measured)
2. specficty (how accurate a test is at identifying people at risk – this is particularly important 
in clinical testing situations)
3. power (the probability of detecting an effect, or degree of change, of a specified size).
21 How to Monitor for Population Health Outcomes: Guidelines for developing a monitoring framework
Determining the sensitivity and specificity of an indicator is often complicated and requires 
specialist knowledge beyond the scope of this How to. The power of your indicator to detect 
changes in the outcome of interest depends on the actual size of the effect (degree of change) 
taking place, or that is expected to take place based on prior experience or the literature. The 
larger the change, the easier it is to detect. 
The power to detect also depends on the background prevalence or incidence of the indicator of 
interest. Finally, the size of the population of interest and the variability in the indicator go hand 
in hand to determine how likely it is your indicator will detect the intervention.
Following are two examples showing how the problem of small numbers in the New Zealand 
population inhibits our ability to statistically identify change in the health status of the 
population due to the effects of an intervention.
Example 2: Power to detect a change n the number of volent offences n a small 
communty
A small community has implemented a programme to reduce interpersonal violence. This 
community collects data on violent offences reported to the local police from one year before 
the programme was initiated. The community has a population of 1000 people and there 
are 25 violent offences reported to the police in the  year before the programme. Overseas 
evidence from similar programmes indicates a reduction in reported offences of 15%. This 
translates to an annual incidence of 25/1000 or 0.025 offences per person per year. A 
reduction of 15% would be just under four fewer cases a year in this community. 
Under this scenario, and if the reduction is actually 15%, the power of this indicator to 
statistically detect the reduction in the following year would be 2.7%. That means if we were 
to run the programme for another 37 years we would on average detect the difference once 
in that time. We would conclude that an indicator with higher incidence would be needed to 
monitor the change made due to the programme.
Figure 2  illustrates this scenario. It simulates a 10-year period for our small community: five 
years before and five years after the violence prevention intervention was initiated at the 
beginning of year six. The pattern highlights the usual statistical variation that one could 
expect to see. Note that in this example, because of the small numbers, it would be very hard 
to argue statistically that the programme has been successful – even though it might have 
been. 
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Fgure 2: Smulated effect of 1% reducton n volent offences
Source: Craig Wright, Public Health Intelligence
Example 3: Power to detect the effects of a health nterventon
The larger the population, or the larger the effect change that we want to detect, the easier it is 
to detect a change. The interaction between the size of the underlying incidence of the health 
issue, a desire to detect a 10% change, and population size is illustrated in Figure 3. Here, 
the three lines indicate the statistical power to detect a 10% change in three populations 
comprising 1000 people, 10,000 people, and 100,000 people, for a health problem that has 
an incidence of 1 to 20% in the population. 
It can be seen that the population of size 1000 never has a power over 20% for the whole 
incidence range of 0–20%, making it unlikely to detect interventions in a population of this 
size. Population 10,000 reaches a reasonable level of power (ie, 80%) at about 9% incidence, 
so it would be unlikely that one would want to use indicators with under a 10% incidence 
in communities of size 10,000 when expecting a reduction of 10%. Finally, indicators in the 
large 100,000 size population are likely to detect a 10% decrease in the indicator above 2% 
incidence (with 80% confidence).
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Fgure 3:  Power to detect change due to an nterventon, for specfied ncdence, populaton 
sze and 10% ncdence reducton
Source: Craig Wright, Public Health Intelligence
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Part D: Avalable Data and Informaton from 
Publc Health Intellgence
Key ponts
1. Public Health Intelligence has data you can use:
a. New Zealand Health Monitor Survey programme population survey data
b. Administrative data, which includes hospital records, disease registrations, and mortality 
data.
2. Go to PHIOnline (www.phionline.moh.govt.nz) to access data.
Public Health Intelligence (PHI) has two main types of data you can utilise as indicators for 
outcomes monitoring: survey data collected from population surveys, and administrative data, 
which includes hospital records, disease registrations, and mortality data.
Survey data
PHI is responsible for the New Zealand Health Monitor (NZHM) survey programme, which is a 
population-based, integrated, ongoing survey programme. Data is collected for the following 
three major health information domains:
• health outcomes (health status, disease states)
• causes of these outcomes (social and environmental determinants, risk and protective 
factors)
• health services (access, utilisation, need, coverage, quality, responsiveness, cost).
There are two main types of vehicles for collecting information in the NZHM programme: serial 
cross-sectional surveys and serial cohort studies. Table 5 presents a summary of the NZHM 
surveys.
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Table : Summary of New Zealand Health Montor surveys, 2002–2012
Survey Topc / data areas
Frame 
(target 
populaton)
Sample Mode Frequency
New 
Zealand 
Health 
Survey
Chronic diseases, 
biological and 
behavioural risk 
factors, reported 
health status, 
health service 
utilisation, 
sociodemographics.
All New 
Zealanders
12,500 
adults 
(15+ years) 
and 5000 
children 
(birth to 14 
years)
Face-to-face, 
computer-assisted 
(CAPI) questionnaire 
plus anthropometric 
measurements in 
respondent’s home.
Previously 
1992/93, 
1996/97, and 
2002/03.  Now 
every three 
years (2006/07, 
2009/10 etc).
Te Rau 
Hinengaro 
New 
Zealand 
Mental 
Health 
Survey
Prevalence, 
severity, 
impairment and 
treatment of major 
mental health 
disorders.
New Zealand 
adults (16+ 
years)
Approx. 
13,000
Face-to-face CAPI 
questionnaire in 
respondent’s home.
Approximately 
every 10 years. 
Previously 2004, 
next planned for 
2014.
New 
Zealand 
Nutrition 
Surveys
Food and nutrient 
intake, factors 
influencing dietary 
intake, nutritional 
status and nutrition-
related status.
New Zealand 
adults (15+ 
years) or 
New Zealand 
children 
(5–14 years)
Approx. 
4000– 
5000 
24-hour dietary 
recall and food 
frequency 
questionnaire, 
self-administered 
questionnaire, plus 
examination, in 
respondent’s home 
or at school for 
children.
Every five years, 
alternating 
between adult 
and child (adult 
1997 next 
2007/08; child 
2002, next 2012).
New 
Zealand 
Oral 
Health 
Survey
Oral health 
status, oral health 
beliefs, attitudes, 
knowledge and 
practices.
All New 
Zealanders
Approx. 
6000 to 
8000
Face-to-face CAPI 
questionnaire and 
oral examination.
Every 10 years 
from  2008.
New 
Zealand 
Tobacco 
Use 
Survey
Tobacco use and 
the psychosocial 
correlates 
of smoking 
behaviours. 
Prevalence and 
consumption data 
available from the 
NZ Health Survey in 
3rd year.
New Zealand 
adults (15 to 
64 years)
Approx. 
4000 to 
6000
Face-to-face CAPI 
questionnaire in 
respondent’s home.
Two out of every 
three years 
(2005, 2006, 
2008, 2009, etc).
New 
Zealand 
Alcohol 
and 
Drug Use 
Survey
Alcohol and illicit 
drug use, and 
the behaviours 
associated with 
alcohol and drug 
use.
New Zealand 
adults (16 to 
64 years)
Approx. 
8000
Face-to-face CAPI 
questionnaire with 
audio-assisted 
self-complete 
section (A-CASI) in 
respondent’s home.
Every two years 
from 2007.
Source: Ministry of Health 2005.  
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In addition to the cross-sectional surveys listed above, PHI is also involved in serial cohort 
studies (often referred to as record linkage studies).  These include the New Zealand Census 
– Mortality Study and Cancer Trends.
Descriptive reports on the results of the above surveys can be found on PHI’s website. Access to 
the unit record survey data sets is available on application; see: www.moh.govt.nz/phi/surveys.
Admnstratve data
PHI often utilises administrative data collected by the New Zealand Health Information Service 
(NZHIS).  These data sources include hospital discharges, cancer registrations and mortality 
data.  Table 6 describes these data sources in more detail.
Table : Summary of admnstratve data sources
Short name of data 
source
Descrpton/keywords
Source of 
data
Perod covered Delay
Mortality data Mortality data from the Mortality 
Data Collection
NZHIS 1970–2003 3 years
Foetal mortality Foetal and infant mortality data 
from the Mortality Data Collection
NZHIS 1988–2003 3 years
Cancer registrations All cancers NZHIS 1950–2004 3 years
Priority sites (lung, female breast, 
cervix, prostate and colorectal)
NZHIS 1950–2004 2 years
Notifiable diseases Notifiable diseases from 
Environmental Science and 
Research’s (ESR’s) schedule
ESR 1997–2006 18 months
Sexually transmitted 
infections
Sexually transmitted infections 
from sexual health clinics
ESR 1997–2003 18 months
Public hospital 
discharges
Public hospital discharge from the 
National Minimum Data Set (NMDS)
NZHIS via 
DHBSPF
1971–2006 6 months
Filtered public hospital 
discharges
Filtered public hospital discharge 
from the NMDS
NZHIS via 
DHBSPF
1988–2006 6 months
Private hospital 
discharges
Private hospital discharge from the 
NMDS
NZHIS 1980–1995, 
2001–2003
Irregularly
Birth registrations Live and still birth registrations 
from the BDM registrations
BDM via 
SNZ
1980–2006 18 months
Mental health services Mental health services from the 
Mental Health Information National 
Collection (MHINC)
NZHIS 2001–2006 6 months
Notes: DHBSPF = District Health Board Service Provision Framework; BDM = Births, Deaths and Marriages; SNZ = Statistics 
New Zealand.
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All of the above data sources are:
• in SAS version 8 file format
• at unit record level
• licensed to Public Health Intelligence, Ministry of Health.
PHIOnlne – www.phonlne.moh.govt.nz
National administrative data and survey data can often be disaggregated to the regional level, 
which may be more useful for your monitoring purposes.  The main access portal for this 
information is PHIOnline. It is a powerful visualisation tool and provides an alternative way 
to access health information through a mapping interface rather than traditional text-based 
documents. Data is displayed for different DHB as well as at the Territorial Local Authority level, 
allowing you to visualise variability within your DHB. 
Fgure 4: The PHIOnlne home page 
The home page provides information for users on accessing the visualisation tool. Each 
visualisation is thought of as an ‘atlas’, and the information has been grouped in accordance to 
the health priorities found in the New Zealand Health Strategy. To view the atlases, just click one 
of the links listed on the left-hand side of the home page shown in Figure 4. 
PHIOnline incorporates a number of formats to view health information on the one web page. 
The interface consists of an interactive map (or maps) with linked tables, charts and graphs. The 
standard view of the website shows the one map as the centrepiece of the interface (Figure 5). 
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The map is thematically drawn in relation to the range and classification of the particular data 
set. 
PHIOnline offers a number of classifications, which the user can experiment with. To complement 
the map, a table of the data is also displayed, as well as a time series of the data set. You can rank 
the data in the table by value, highest-to-lowest or lowest-to-highest, as well as by alphabetical 
order. Data is displayed by region as well as providing a national figure. You can download all data 
displayed on the site. The site also contains extensive metadata for each data set.
Fgure : PHIOnlne sngle map nterface
Another interface allows you to compare two different health data sets, displaying two maps on 
the one web page (see Figure 6). A scatter plot for both data sets is also displayed.
In addition to survey and administrative data, PHIOnline contains data on:
• oral health
• Get Checked diabetes
• water quality
• elected services
• problem gambling.
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Fgure : PHIOnlne double map nterface
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pr
ia
te
 p
ro
xy
 in
di
ca
to
r,
 o
r w
he
th
er
 in
fo
rm
at
io
n 
fr
om
 a
n 
al
re
ad
y 
ex
is
ti
ng
 m
on
ito
ri
ng
 re
gi
m
e 
co
ul
d 
be
 u
se
d.
 
In
 g
en
er
al
, t
he
 p
ro
po
rt
io
n 
of
 th
e 
to
ta
l b
ud
ge
t s
pe
nt
 o
n 
m
on
ito
ri
ng
 
sh
ou
ld
 b
e 
in
 th
e 
re
gi
on
 o
f 5
%
 to
 2
0%
, d
ep
en
di
ng
 o
n 
th
e 
ty
pe
 a
nd
 
si
ze
 o
f t
he
 p
ro
gr
am
m
e.
 W
he
re
 th
e 
pr
og
ra
m
m
e 
is
 a
 p
ilo
t i
ni
tia
ti
ve
, 
th
e 
re
su
lt
s 
of
 w
hi
ch
 c
ou
ld
 b
e 
us
ed
 to
 s
ig
ni
fic
an
tl
y 
in
flu
en
ce
 
w
he
th
er
 th
e 
pr
og
ra
m
m
e 
is
 e
xp
an
de
d 
in
to
 a
 m
aj
or
 e
ff
or
t,
 th
en
 
20
%
 o
f t
he
 to
ta
l b
ud
ge
t c
ou
ld
 b
e 
ap
pr
op
ri
at
e.
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Te
rm
D
efi
n
to
n
Ex
pl
an
at
or
y 
co
m
m
en
t a
nd
 e
xa
m
pl
e
• 
co
st
-e
ffi
ci
en
cy
, w
hi
ch
 is
 a
 m
et
ho
d 
by
 w
hi
ch
 th
e 
co
st
 p
er
 o
ut
pu
t i
s 
m
ea
su
re
d.
 T
hi
s 
ap
pr
oa
ch
 is
 li
ke
ly
 to
 b
e 
pa
rt
ic
ul
ar
ly
 a
pp
ro
pr
ia
te
 
w
he
re
 th
e 
se
rv
ic
e 
pr
ov
id
ed
 (e
g,
 a
 p
ub
lic
 h
ea
lt
h 
in
fo
rm
at
io
n 
se
rv
ic
e)
 is
 re
m
ot
e 
fr
om
 a
ny
 h
ea
lt
h 
ou
tc
om
e.
H
ow
ev
er
, i
f t
he
 p
ro
gr
am
m
e 
ha
s 
a 
la
rg
e 
bu
dg
et
 a
nd
 th
e 
pr
og
ra
m
m
e 
is
 w
el
l e
st
ab
lis
he
d,
 a
pp
lie
d 
in
 s
ta
nd
ar
d 
w
ay
s 
an
d 
su
pp
or
te
d 
by
 e
vi
de
nc
e 
fo
r i
ts
 e
ff
ec
ti
ve
ne
ss
, t
he
n 
a 
bu
dg
et
 
al
lo
ca
ti
on
 o
f 5
%
 m
ay
 b
e 
ap
pr
op
ri
at
e 
fo
r m
on
ito
ri
ng
 p
ur
po
se
s.
  
Co
st
 p
er
 o
ut
pu
t i
s 
pr
ob
ab
ly
 th
e 
be
st
 m
et
ho
d 
to
 u
se
 w
he
n 
ca
lc
ul
at
in
g 
th
e 
co
st
 o
f a
 m
on
ito
ri
ng
 p
ro
gr
am
m
e 
or
 a
 c
om
po
ne
nt
 
of
 it
.  
Fo
r e
xa
m
pl
e,
 th
e 
co
st
 o
f p
ur
ch
as
in
g 
in
fo
rm
at
io
n 
fr
om
 a
n 
ex
is
ti
ng
 d
at
a 
se
t m
ay
 b
e 
ch
ea
pe
r t
ha
n 
do
in
g 
it 
yo
ur
se
lf.
 O
r,
 it
 m
ay
 
be
 c
he
ap
er
 to
 u
se
 a
 p
ro
xy
 m
ea
su
re
 th
an
 to
 u
se
 a
 d
ir
ec
t m
ea
su
re
 
–
 a
ss
um
in
g 
th
e 
pr
ox
y 
m
ea
su
re
 is
 ro
bu
st
 e
no
ug
h 
to
 w
it
hs
ta
nd
 
pu
bl
ic
 s
cr
ut
in
y 
an
d 
th
e 
in
fo
rm
at
io
n 
tr
ad
e-
of
f i
s 
ac
ce
pt
ab
le
. N
ot
e 
th
at
 c
os
t e
ff
ec
ti
ve
ne
ss
 is
 ju
st
 o
ne
 o
f a
 n
um
be
r o
f c
ri
te
ri
a 
th
at
 
sh
ou
ld
 b
e 
us
ed
 in
 p
la
nn
in
g 
an
 o
ut
co
m
es
 m
on
ito
ri
ng
 re
gi
m
e.
 
D
at
a
   
 D
at
a 
se
ts
D
at
a 
is
 fa
ct
ua
l i
nf
or
m
at
io
n 
th
at
 a
ft
er
 a
na
ly
si
s 
is
 u
se
d 
to
 re
as
on
 o
r 
m
ak
e 
de
ci
si
on
s.
 T
he
 w
or
d 
is
 c
om
m
on
ly
 u
se
d 
to
 re
fe
r t
o 
ei
th
er
 s
in
gl
e 
or
 m
ul
ti
pl
e 
pi
ec
es
 o
f i
nf
or
m
at
io
n,
 a
nd
 in
 te
ch
ni
ca
l r
ep
or
ts
 is
 o
ft
en
 
us
ed
 in
 th
e 
pl
ur
al
 fo
rm
 (a
s 
in
 ‘d
at
a 
ar
e 
co
lle
ct
ed
’)
. 
D
at
a 
se
ts
 re
fe
rs
 to
 c
ol
le
ct
io
ns
 o
f p
ie
ce
s 
of
 in
fo
rm
at
io
n 
th
at
 a
re
 
co
lle
ct
ed
 fo
r p
ar
ti
cu
la
r p
ur
po
se
s.
 ‘D
at
a 
se
ts
’ i
s 
sy
no
ny
m
ou
s 
w
it
h 
da
ta
ba
se
s.
Fo
r e
xa
m
pl
e,
 th
e 
Ph
ar
m
ho
us
e 
da
ta
 s
et
 c
ol
le
ct
s 
pi
ec
es
 o
f 
in
fo
rm
at
io
n 
ab
ou
t t
he
 p
re
sc
ri
bi
ng
 o
f d
ru
gs
 s
ub
si
di
se
d 
in
 N
ew
 
Ze
al
an
d 
by
 P
ha
rm
ac
. 
Th
e 
N
ew
 Z
ea
la
nd
 H
ea
lt
h 
In
fo
rm
at
io
n 
S
er
vi
ce
 is
 re
sp
on
si
bl
e 
fo
r t
he
 
co
lle
ct
io
n 
an
d 
m
ai
nt
en
an
ce
 o
f m
an
y 
of
 th
e 
la
rg
e 
na
ti
on
al
 h
ea
lt
h-
re
la
te
d 
da
ta
 s
et
s,
 s
uc
h 
as
 m
or
ta
lit
y 
an
d 
m
or
bi
di
ty
 d
at
a.
 O
th
er
 
go
ve
rn
m
en
t a
ge
nc
ie
s 
ar
e 
re
sp
on
si
bl
e 
fo
r o
th
er
 d
at
a 
se
ts
 th
at
 
ca
n 
be
 u
se
fu
l f
or
 m
on
ito
ri
ng
 p
ub
lic
 h
ea
lt
h 
pr
og
ra
m
m
es
. A
 la
rg
e 
nu
m
be
r o
f t
he
se
 d
at
a 
se
ts
 a
re
 h
os
te
d 
on
 th
e 
PH
IO
nl
in
e 
w
eb
si
te
 
(w
w
w
.p
hi
on
lin
e.
m
oh
.g
ov
t.
nz
).
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Te
rm
D
efi
n
to
n
Ex
pl
an
at
or
y 
co
m
m
en
t a
nd
 e
xa
m
pl
e
Ev
al
ua
to
n
   
  F
or
m
at
v
e
   
  P
ro
ce
ss
   
  I
m
pa
ct
Ev
al
ua
ti
on
 is
 a
 re
se
ar
ch
 p
ro
ce
ss
 th
at
 a
im
s 
to
 a
ss
es
s 
sy
st
em
at
ic
al
ly
 
an
d 
ob
je
ct
iv
el
y 
th
e 
re
le
va
nc
e,
 p
er
fo
rm
an
ce
 a
nd
 s
uc
ce
ss
 o
f o
ng
oi
ng
 
or
 c
om
pl
et
ed
 p
ro
gr
am
m
es
.  
Ev
al
ua
ti
on
 a
im
s 
to
 p
ro
vi
de
 in
fo
rm
at
io
n 
ab
ou
t w
he
th
er
 u
nd
er
ly
in
g 
as
su
m
pt
io
ns
 o
r t
he
or
ie
s 
us
ed
 in
 th
e 
pr
og
ra
m
m
e 
de
ve
lo
pm
en
t w
er
e 
va
lid
, w
ha
t w
or
ke
d 
an
d 
w
ha
t d
id
 n
ot
 
w
or
k,
 a
nd
 w
hy
. T
yp
ic
al
ly
 e
va
lu
at
io
n 
ai
m
s 
to
 d
et
er
m
in
e 
th
e 
re
le
va
nc
e,
 
ef
fic
ie
nc
y,
 e
ff
ec
ti
ve
ne
ss
, i
m
pa
ct
 a
nd
 s
us
ta
in
ab
ili
ty
 o
f a
 p
ro
gr
am
m
e.
 
Ev
al
ua
ti
on
 s
ho
ul
d 
al
lo
w
 fo
r l
es
so
ns
 le
ar
nt
 to
 b
e 
tr
an
sf
er
re
d 
in
to
 
ot
he
r p
ro
gr
am
m
es
. 
A
 c
om
pr
eh
en
si
ve
 e
va
lu
at
io
n 
pr
og
ra
m
m
e 
us
ua
lly
 in
vo
lv
es
 th
re
e 
pa
rt
s:
• 
fo
rm
at
iv
e 
ev
al
ua
ti
on
 
• 
pr
oc
es
s 
ev
al
ua
ti
on
• 
im
pa
ct
/o
ut
co
m
e 
ev
al
ua
ti
on
.
Fo
rm
at
iv
e 
ev
al
ua
tio
n 
fo
cu
se
s 
on
 th
e 
es
ta
bl
is
hm
en
t o
f t
he
 
pr
og
ra
m
m
e.
  I
t i
s 
pa
rt
ic
ul
ar
ly
 u
se
fu
l w
he
n 
th
e 
pr
og
ra
m
m
e 
is
 
ne
w
, u
nt
es
te
d 
an
d 
re
qu
ir
es
 c
om
m
un
it
y 
ac
ce
pt
an
ce
 if
 it
 is
 to
 
be
 s
uc
ce
ss
fu
l. 
It 
se
ek
s 
to
 u
nd
er
st
an
d 
w
ha
t t
he
 c
on
di
ti
on
s 
fo
r 
pr
og
ra
m
m
e 
su
cc
es
s 
ar
e 
su
pp
os
ed
 to
 b
e.
Pr
oc
es
s 
ev
al
ua
tio
n 
fo
cu
se
s 
on
 h
ow
 w
el
l t
he
 p
ro
gr
am
m
e 
fu
nc
ti
on
s.
 
A
re
 th
e 
co
nd
it
io
ns
 fo
r s
uc
ce
ss
 p
re
se
nt
 in
 th
e 
w
ay
 th
e 
pr
og
ra
m
m
e 
is
 
be
in
g 
de
liv
er
ed
?
Im
pa
ct
 /
ou
tc
om
e 
ev
al
ua
tio
n 
as
se
ss
es
 h
ow
 s
uc
ce
ss
fu
l t
he
 
pr
og
ra
m
m
e 
ha
s 
be
en
 in
 d
el
iv
er
in
g 
th
e 
de
si
re
d 
ou
tc
om
es
. I
m
pa
ct
 
ev
al
ua
ti
on
 s
ho
ul
d 
al
w
ay
s 
tr
y 
to
 id
en
ti
fy
 u
ni
nt
en
de
d 
be
ne
fit
s 
an
d 
an
y 
ne
ga
ti
ve
 p
ro
gr
am
m
e 
co
ns
eq
ue
nc
es
.
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Te
rm
D
efi
n
to
n
Ex
pl
an
at
or
y 
co
m
m
en
t a
nd
 e
xa
m
pl
e
O
th
er
 te
rm
s 
th
at
 m
ay
 b
e 
as
so
ci
at
ed
 w
it
h 
ev
al
ua
ti
on
 in
cl
ud
e:
 
• 
ou
tp
ut
• 
ou
tc
om
e
• 
im
pa
ct
.
Ev
d
en
ce
d-
ba
se
d 
pu
bl
c
 h
ea
lth
 
(E
BP
H
)
D
efi
ni
ti
on
s 
of
 w
ha
t ‘
ev
id
en
ce
d 
ba
se
d 
pu
bl
ic
 h
ea
lt
h’
 m
ea
ns
 a
re
 
ev
ol
vi
ng
 (K
oh
at
su
 e
t a
l 2
00
4)
. I
n 
th
e 
co
nt
ex
t o
f t
he
 G
ui
de
 to
 
D
ev
el
op
in
g 
Pu
bl
ic
 H
ea
lth
 P
ro
gr
am
m
es
: A
 g
en
er
ic
 p
ro
gr
am
m
e 
lo
gi
c 
m
od
el
 (M
in
is
tr
y 
of
 H
ea
lt
h 
20
06
) a
nd
 th
is
 H
ow
 to
, t
he
 d
efi
ni
ti
on
 b
y 
B
ro
w
ns
on
 (2
00
3)
 is
 p
re
fe
rr
ed
:
 
EB
PH
 is
 th
e 
de
ve
lo
pm
en
t,
 im
pl
em
en
ta
ti
on
, a
nd
 e
va
lu
at
io
n 
of
 e
ff
ec
ti
ve
 p
ro
gr
am
s 
an
d 
po
lic
ie
s 
in
 p
ub
lic
 h
ea
lt
h 
th
ro
ug
h 
ap
pl
ic
at
io
n 
of
 p
ri
nc
ip
le
s 
of
 s
ci
en
ti
fic
 re
as
on
in
g,
 in
cl
ud
in
g 
sy
st
em
at
ic
 u
se
s 
of
 d
at
a 
an
d 
in
fo
rm
at
io
n 
sy
st
em
s 
an
d 
ap
pr
op
ri
at
e 
us
e 
of
 p
ro
gr
am
 p
la
nn
in
g 
m
od
el
s.
 
S
ee
 a
ls
o 
Ko
ha
ts
u 
(2
00
4)
 a
nd
 Je
ni
ce
k 
(1
99
7)
 fo
r a
lte
rn
at
iv
e 
fo
rm
ul
at
io
ns
 d
efi
ni
ng
 E
B
PH
. K
oh
at
su
’s
 (2
00
4)
 fo
rm
ul
at
io
n 
is
 
ap
pl
ic
ab
le
 to
 th
e 
po
lic
y 
de
ve
lo
pm
en
t p
ro
ce
ss
, w
hi
le
 Je
ni
ce
k’
s 
(1
99
7)
 d
efi
ni
ti
on
 is
 a
n 
ap
pl
ic
at
io
n 
of
 e
vi
de
nc
e-
ba
se
d 
m
ed
ic
in
e 
co
nc
ep
ts
 to
 p
ub
lic
 h
ea
lt
h 
pr
ac
ti
ce
. 
(S
ee
 a
ls
o 
Pu
bl
ic
 h
ea
lt
h.
)
Im
pa
ct
s
Im
pa
ct
s 
ar
e 
th
e 
co
nt
ri
bu
ti
on
 m
ad
e 
to
 th
e 
ac
hi
ev
em
en
t o
f a
n 
ou
tc
om
e 
by
 a
 s
pe
ci
fie
d 
se
t o
f a
ct
io
ns
 (T
he
 T
re
as
ur
y 
an
d 
S
ta
te
 
S
er
vi
ce
s 
Co
m
m
is
si
on
 2
00
7b
).
 
Im
pa
ct
s 
sh
ou
ld
 b
e 
po
si
ti
ve
, a
lt
ho
ug
h 
un
in
te
nd
ed
 c
on
se
qu
en
ce
s 
fr
om
 a
n 
ac
ti
on
 m
ay
 o
cc
ur
 th
at
 re
su
lt 
in
 e
it
he
r p
os
it
iv
e 
or
 n
eg
at
iv
e 
co
nt
ri
bu
ti
on
s 
to
 th
e 
ac
hi
ev
em
en
t o
f t
he
 d
es
ir
ed
 o
ut
co
m
e.
 
N
ot
e:
 th
is
 d
efi
ni
ti
on
 a
nd
 u
se
 o
f ‘
im
pa
ct
’ a
re
 d
iff
er
en
t t
o 
ho
w
 
it 
is
 d
efi
ne
d 
an
d 
us
ed
 in
 e
va
lu
at
io
n 
m
et
ho
do
lo
gy
 (s
ee
 a
ls
o 
Ev
al
ua
ti
on
).
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Te
rm
D
efi
n
to
n
Ex
pl
an
at
or
y 
co
m
m
en
t a
nd
 e
xa
m
pl
e
In
d
ca
to
rs
 
Q
ua
nt
ta
tv
e
 
Q
ua
lt
at
v
e
 
Pr
ox
y
In
di
ca
to
rs
 a
re
 e
it
he
r q
ua
nt
ita
ti
ve
 o
r q
ua
lit
at
iv
e 
m
ea
su
re
s 
th
at
 
as
se
ss
 th
e 
di
re
ct
io
n 
an
d 
si
ze
 o
f c
ha
ng
e 
in
 th
e 
th
in
g 
be
in
g 
m
ea
su
re
d.
 
Q
ua
nt
ita
tiv
e 
in
di
ca
to
rs
 a
re
 n
um
er
ic
al
 m
ea
su
re
m
en
ts
 th
at
 le
nd
 
th
em
se
lv
es
 to
 s
ta
tis
ti
ca
l a
na
ly
si
s.
 (T
hi
s 
H
ow
 to
 fo
cu
se
s 
on
 th
is
 
ty
pe
 o
f i
nd
ic
at
or
).
 Q
ua
lit
at
iv
e 
in
di
ca
to
rs
 a
re
 p
ri
m
ar
ily
 m
ea
su
re
s 
ta
ke
n 
in
 a
 te
xt
ua
l (
na
rr
at
iv
e)
 fo
rm
 (i
e,
 n
on
-n
um
er
ic
al
) a
nd
 m
ay
 o
r 
m
ay
 n
ot
 le
nd
 th
em
se
lv
es
 to
 q
ua
nt
ifi
ca
ti
on
. A
na
ly
si
s 
of
 q
ua
lit
at
iv
e 
in
di
ca
to
rs
 re
qu
ir
es
 th
e 
us
e 
of
 q
ua
lit
at
iv
e 
an
al
yt
ic
al
 te
ch
ni
qu
es
. 
Pr
ox
y 
in
di
ca
to
rs
 a
re
 m
ea
su
re
s 
th
at
 p
ro
vi
de
 a
n 
ap
pr
ox
im
at
e 
es
ti
m
at
e 
of
 c
ha
ng
e 
in
 th
e 
ou
tc
om
e 
of
 in
te
re
st
. P
ro
xy
 m
ea
su
re
s 
m
ay
 b
e 
ap
pr
op
ri
at
e 
to
 u
se
 w
he
n 
di
re
ct
 m
ea
su
re
s 
ca
nn
ot
 b
e 
us
ed
 b
ec
au
se
 
of
 c
on
ce
rn
s 
ab
ou
t e
th
ic
s,
 c
os
t,
 c
om
pl
ex
it
y 
of
 m
ea
su
re
m
en
t o
r 
ti
m
el
in
es
s.
 F
or
 e
xa
m
pl
e,
 h
os
pi
ta
lis
at
io
ns
 fo
r i
nt
en
ti
on
al
 s
el
f-
ha
rm
 
ar
e 
us
ed
 a
s 
an
 a
cc
ep
ta
bl
e 
pr
ox
y 
m
ea
su
re
 o
f s
ui
ci
de
 a
tt
em
pt
, a
nd
 
B
M
I i
s 
us
ua
lly
 a
cc
ep
te
d 
as
 a
 p
ro
xy
 fo
r o
be
si
ty
.  
(S
ee
 a
ls
o 
In
st
ru
m
en
t.)
Ti
m
e 
is
 a
n 
im
po
rt
an
t f
ac
to
r i
n 
as
se
ss
in
g 
w
ha
t c
ha
ng
e 
ha
s 
oc
cu
rr
ed
.  
In
di
ca
to
rs
 m
ay
 m
ea
su
re
 c
ha
ng
e 
ov
er
 th
e 
sh
or
t,
 
m
ed
iu
m
 o
r l
on
g 
te
rm
. W
ha
t c
on
st
itu
te
s 
sh
or
t,
 m
ed
iu
m
 o
r l
on
g 
te
rm
 d
ep
en
ds
 o
n 
th
e 
co
nt
ex
t a
nd
 th
e 
is
su
e(
s)
 th
e 
pr
og
ra
m
m
e 
is
 
ta
ck
lin
g.
  
H
ea
lt
h 
in
di
ca
to
rs
 d
ir
ec
tl
y 
or
 in
di
re
ct
ly
 (i
e,
 p
ro
xy
) m
ea
su
re
 a
 
he
al
th
-r
el
at
ed
 c
ha
ra
ct
er
is
ti
c 
of
 a
n 
in
di
vi
du
al
, p
op
ul
at
io
n 
or
 th
e 
en
vi
ro
nm
en
t.
 T
he
 in
di
ca
to
r m
ay
 m
ea
su
re
 o
ne
 o
r m
or
e 
he
al
th
 
as
pe
ct
s 
(q
ua
lit
y,
 q
ua
nt
it
y 
an
d 
ti
m
e)
 (N
ut
be
am
 1
99
8)
.
In
pu
ts
Re
so
ur
ce
s 
pu
t i
nt
o 
a 
pr
og
ra
m
m
e 
to
 c
ar
ry
 o
ut
 a
n 
ac
ti
vi
ty
. A
no
th
er
 
te
rm
 fo
r i
np
ut
 is
 ‘e
ff
or
t’
.  
In
pu
ts
 c
an
 b
e 
hu
m
an
, m
at
er
ia
l, 
fin
an
ci
al
 o
r e
xp
re
ss
ed
 a
s 
ti
m
e.
 
Ef
fo
rt
 d
es
cr
ib
es
 e
ve
ry
th
in
g 
th
at
 ‘w
e’
 u
se
 a
nd
 d
o 
fo
r ‘
th
em
’ –
 th
e 
pr
og
ra
m
m
e 
re
ci
pi
en
ts
.
In
st
ru
m
en
t
A
n 
in
st
ru
m
en
t i
s 
a 
nu
m
er
ic
al
 o
r t
ex
t-
ba
se
d 
m
ea
su
ri
ng
 m
et
ho
d 
th
at
 
sh
ow
s 
th
e 
ex
te
nt
 o
r a
m
ou
nt
 o
r q
ua
nt
it
y 
or
 d
eg
re
e 
of
 s
om
et
hi
ng
 o
f 
in
te
re
st
.  
Th
e 
in
st
ru
m
en
t i
s 
th
e 
pr
oc
es
s 
us
ed
 to
 p
ro
du
ce
 th
e 
de
si
re
d 
pu
bl
ic
 
he
al
th
 in
di
ca
to
r.
 (S
ee
 In
d
ca
to
rs
.) 
 
M
ea
su
re
(s
)
S
ee
 In
d
ca
to
rs
 a
nd
 In
st
ru
m
en
t.
M
et
r
c(
s)
S
ee
 In
d
ca
to
rs
 a
nd
 In
st
ru
m
en
t.
M
on
to
r
S
ee
 O
ut
co
m
es
 m
on
to
r
ng
.
37 How to Monitor for Population Health Outcomes: Guidelines for developing a monitoring framework
Te
rm
D
efi
n
to
n
Ex
pl
an
at
or
y 
co
m
m
en
t a
nd
 e
xa
m
pl
e
O
bj
ec
tv
es
  H
g
h-
or
de
r/
ge
ne
ra
l
 S
pe
c
fic
/ 
 
nt
er
m
ed
a
te
 L
ow
-o
rd
er
/ 
  
 o
pe
ra
to
na
l
   
SM
AR
T
O
bj
ec
ti
ve
s 
ar
e 
st
at
em
en
ts
 a
bo
ut
 th
e 
re
su
lt
s 
a 
pr
og
ra
m
m
e 
se
ek
s 
to
 a
ch
ie
ve
. A
ny
 p
ro
gr
am
m
e 
m
us
t h
av
e 
at
 le
as
t o
ne
 o
bj
ec
ti
ve
. 
O
bj
ec
ti
ve
s 
m
ay
 b
e 
tr
an
sl
at
ed
 d
ir
ec
tl
y 
in
to
 ‘o
ut
co
m
es
’ w
he
re
 th
ey
 
de
al
 w
it
h 
on
ly
 o
ne
 is
su
e.
 H
ow
ev
er
, d
ou
bl
e-
ba
rr
el
le
d 
ob
je
ct
iv
es
 w
ill
 
re
qu
ir
e 
m
ul
ti
pl
e 
ou
tc
om
e 
m
ea
su
re
s 
to
 b
e 
de
ve
lo
pe
d.
 
O
bj
ec
ti
ve
s 
m
ay
 fo
rm
 a
 h
ie
ra
rc
hy
 th
at
 m
ov
es
 fr
om
 a
 li
m
ite
d 
se
t o
f 
hi
gh
-o
rd
er
 o
bj
ec
ti
ve
s 
th
at
 a
re
 s
yn
on
ym
ou
s 
w
it
h 
ai
m
s 
or
 g
oa
ls
, t
o 
lo
w
er
-o
rd
er
 o
r m
or
e 
sp
ec
ifi
c 
or
 in
te
rm
ed
ia
te
 o
bj
ec
ti
ve
s,
 a
s 
fo
llo
w
s.
H
ig
h-
or
de
r o
r g
en
er
al
 o
bj
ec
tiv
es
 a
re
 s
ta
te
m
en
ts
 a
bo
ut
 th
e 
ov
er
-a
ll 
or
 lo
ng
-t
er
m
 e
ff
ec
ts
 o
r u
lt
im
at
e 
ou
tc
om
es
 th
at
 a
re
 e
xp
ec
te
d 
to
 b
e 
ob
ta
in
ed
 a
s 
a 
re
su
lt 
of
 th
e 
pr
og
ra
m
m
e,
 o
r t
o 
w
hi
ch
 th
e 
pr
og
ra
m
m
e 
co
nt
ri
bu
te
s 
to
 a
s 
pa
rt
 o
f a
 w
ho
le
-o
f-
go
ve
rn
m
en
t i
ni
tia
ti
ve
. 
A
tt
ai
nm
en
t o
f h
ig
h-
or
de
r o
bj
ec
ti
ve
s 
m
ay
 o
r m
ay
 n
ot
 b
e 
di
re
ct
ly
 
at
tr
ib
ut
ab
le
 to
 a
ny
 o
ne
 p
ro
gr
am
m
e.
  L
on
g-
te
rm
 o
bj
ec
ti
ve
s 
ar
e 
ge
ne
ra
lly
 th
os
e 
to
 b
e 
ac
hi
ev
ed
 in
 5
 to
 1
0 
ye
ar
s.
Sp
ec
ifi
c 
or
 in
te
rm
ed
ia
te
-l
ev
el
 o
bj
ec
tiv
es
 a
re
  s
ta
te
m
en
ts
 a
bo
ut
 
th
e 
in
te
rm
ed
ia
te
 o
ut
co
m
es
 th
at
 a
re
 e
xp
ec
te
d 
to
 b
e 
ac
hi
ev
ed
 b
y 
th
e 
pr
og
ra
m
m
e,
 a
nd
 th
at
 a
re
 m
or
e 
di
re
ct
ly
 a
tt
ri
bu
ta
bl
e 
to
 th
e 
pr
og
ra
m
m
e’
s 
ac
ti
vi
ti
es
. T
he
se
 o
bj
ec
ti
ve
s 
ar
e 
ge
ne
ra
lly
 th
os
e 
to
 b
e 
ac
hi
ev
ed
 in
 3
 to
 5
 y
ea
rs
.
Lo
w
-o
rd
er
 o
r o
pe
ra
tio
na
l o
bj
ec
tiv
es
 a
re
 s
ta
te
m
en
ts
 a
bo
ut
 th
e 
im
m
ed
ia
te
 o
ut
co
m
es
 (w
hi
ch
 m
ay
 b
e 
ex
pr
es
se
d 
as
 o
ut
pu
ts
 in
 
so
m
e 
ci
rc
um
st
an
ce
s)
 e
xp
ec
te
d 
to
 b
e 
ac
hi
ev
ed
 o
r a
cc
om
pl
is
he
d 
fr
om
 th
e 
in
te
rv
en
ti
on
 th
at
 a
re
 d
ir
ec
tl
y 
at
tr
ib
ut
ab
le
 to
 th
e 
ac
ti
vi
ti
es
 
un
de
rt
ak
en
. T
he
se
 o
bj
ec
ti
ve
s 
ar
e 
ge
ne
ra
lly
 th
os
e 
to
 b
e 
ac
hi
ev
ed
 in
  
1 
to
 2
 y
ea
rs
.
In
 te
rm
s 
of
 th
e 
Pu
bl
ic
 F
in
an
ce
 A
ct
 2
00
4,
 o
bj
ec
ti
ve
s 
ar
e 
no
t 
ex
pr
es
sl
y 
de
fin
ed
, a
nd
 c
on
se
qu
en
tl
y 
ca
n 
be
 s
ee
n 
as
 m
ea
ni
ng
 a
 
go
al
 o
r a
im
. H
ow
ev
er
, b
ec
au
se
 s
om
e 
co
re
 d
ep
ar
tm
en
ta
l a
ct
iv
it
ie
s 
th
at
 s
er
vi
ce
 th
e 
op
er
at
io
n 
of
 g
ov
er
nm
en
t d
o 
no
t fi
t w
it
hi
n 
th
e 
de
fin
it
io
n 
of
 a
n 
ou
tc
om
e 
gi
ve
n 
in
 th
e 
A
ct
, o
bj
ec
ti
ve
s 
ar
e 
al
so
 s
ee
n 
as
 b
ei
ng
 s
im
ila
r t
o 
im
pa
ct
s 
an
d 
ou
tc
om
es
. (
S
ee
 O
ut
co
m
es
.)
 (T
he
 
Tr
ea
su
ry
 a
nd
 S
ta
te
 S
er
vi
ce
s 
Co
m
m
is
si
on
 2
00
7a
.)
In
 h
ea
lt
h 
te
rm
s,
 h
ea
lt
h 
go
al
s 
(o
bj
ec
ti
ve
s/
ai
m
s)
 a
re
 g
en
er
al
 
st
at
em
en
ts
 o
f i
nt
en
t a
nd
 d
ir
ec
ti
on
 s
et
 fo
r a
 h
ea
lt
h 
pr
og
ra
m
m
e,
 
w
hi
ch
 m
ay
 in
cl
ud
e 
a 
he
al
th
 ta
rg
et
 to
 a
ch
ie
ve
 (N
ut
be
am
 1
99
8)
. 
In
 th
is
 d
oc
um
en
t,
 th
e 
te
rm
 ‘o
bj
ec
ti
ve
’ i
s 
us
ed
 to
 id
en
ti
fy
 
pa
rt
ic
ul
ar
 re
su
lt
s 
th
e 
pr
og
ra
m
m
e 
se
ek
s 
to
 a
ch
ie
ve
. F
or
 m
on
ito
ri
ng
 
pu
rp
os
es
, t
he
 re
su
lt 
m
ay
 b
e 
ex
pr
es
se
d 
in
 te
rm
s 
of
 a
n 
ou
tc
om
e 
or
 
an
 o
ut
pu
t.
 (S
ee
 O
ut
co
m
es
 a
nd
 O
ut
pu
ts
.)
Fo
llo
w
in
g 
is
 a
n 
ex
am
pl
e 
of
 a
 h
ie
ra
rc
hy
 o
f o
bj
ec
ti
ve
s.
H
ig
h-
or
de
r o
bj
ec
tiv
e 
(s
yn
on
ym
ou
s 
w
it
h 
vi
si
on
, a
im
 o
r g
oa
l)
:
• 
En
ab
le
 p
eo
pl
e 
w
it
h 
ch
ro
ni
c 
co
nd
it
io
ns
 to
 im
pr
ov
e 
th
ei
r 
he
al
th
, s
lo
w
 p
ro
gr
es
s 
of
 th
ei
r c
on
di
ti
on
(s
),
 a
nd
 m
ai
nt
ai
n 
in
de
pe
nd
en
ce
 w
he
re
ve
r p
os
si
bl
e 
by
 a
lig
ni
ng
 c
om
m
un
it
y 
an
d 
ho
sp
ita
l s
er
vi
ce
s 
ac
ro
ss
 [ 
 ] 
D
H
B
.
In
te
rm
ed
ia
te
-l
ev
el
 o
bj
ec
tiv
e 
as
so
ci
at
ed
 w
ith
 a
ch
ie
vi
ng
 th
e 
hi
gh
-
le
ve
l o
bj
ec
tiv
e:
• 
Re
du
ce
 th
e 
in
ci
de
nc
e 
of
 c
an
ce
r,
 d
ia
be
te
s,
 a
nd
 c
ar
di
ov
as
cu
la
r 
di
se
as
e 
by
 2
0%
 re
sp
ec
ti
ve
ly
 o
ve
r t
he
 n
ex
t 5
 y
ea
rs
. 
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Te
rm
D
efi
n
to
n
Ex
pl
an
at
or
y 
co
m
m
en
t a
nd
 e
xa
m
pl
e
O
bj
ec
ti
ve
s 
sh
ou
ld
 b
e 
w
ri
tt
en
 a
s 
SM
AR
T 
ob
je
ct
iv
es
:
• 
Sp
ec
ifi
c
• 
M
ea
su
ra
bl
e
• 
Ac
hi
ev
ab
le
 (s
om
et
im
es
 re
fe
rr
ed
 to
 a
s 
‘a
cc
ur
at
e’
 o
r ‘
ac
ti
on
-
or
ie
nt
ed
’)
• 
Re
le
va
nt
 (s
om
et
im
es
 re
fe
rr
ed
 to
 a
s 
‘r
ea
lis
ti
c’
)
• 
Ti
m
e-
ba
se
d.
Lo
w
-o
rd
er
 o
r o
pe
ra
ti
on
al
 o
bj
ec
ti
ve
s 
as
so
ci
at
ed
 w
it
h 
ac
hi
ev
in
g 
th
e 
in
te
rm
ed
ia
te
 le
ve
l: 
• 
In
cr
ea
se
 th
e 
le
ve
l o
f k
no
w
le
dg
e 
by
 5
0%
 in
 th
e 
ta
rg
et
 
po
pu
la
ti
on
 g
ro
up
s 
ab
ou
t t
he
 c
au
se
s 
an
d 
pr
ev
en
ti
on
 o
f b
re
as
t 
an
d 
pr
os
tr
at
e 
ca
nc
er
, d
ia
be
te
s 
an
d 
ca
rd
io
va
sc
ul
ar
 d
is
ea
se
. 
• 
In
cr
ea
se
 th
e 
up
ta
ke
 o
f c
an
ce
r s
cr
ee
ni
ng
 s
er
vi
ce
s 
by
 5
0%
 in
 th
e 
hi
gh
-r
is
k 
po
pu
la
ti
on
s 
in
 th
e 
ne
xt
 3
 y
ea
rs
.
• 
In
cr
ea
se
 a
cc
es
s 
by
 5
0%
 to
 e
ar
ly
 d
ia
gn
os
is
 s
er
vi
ce
s 
in
 ru
ra
l 
co
m
m
un
it
ie
s 
in
 th
e 
ne
xt
 2
 y
ea
rs
.
O
ut
co
m
es
 
In
te
rm
ed
a
te
 
Cr
os
s-
ag
en
cy
 
Pr
oc
es
s
O
ut
co
m
es
 a
re
 s
pe
ci
fic
 s
ta
te
m
en
ts
 a
bo
ut
 th
e 
in
te
nd
ed
 c
ha
ng
e 
in
 
pu
bl
ic
 h
ea
lt
h-
re
la
te
d 
at
ti
tu
de
s,
 k
no
w
le
dg
e,
 b
eh
av
io
ur
s,
 o
r p
hy
si
ca
l 
(i
nc
lu
di
ng
 m
en
ta
l)
 h
ea
lt
h 
st
at
us
 in
 th
e 
ta
rg
et
 p
op
ul
at
io
n(
s)
 s
ou
gh
t 
by
 u
nd
er
ta
ki
ng
 th
e 
pl
an
ne
d 
pu
bl
ic
 h
ea
lt
h 
ac
ti
vi
ty
. 
In
te
rm
ed
ia
te
 o
ut
co
m
es
 (a
ls
o 
ca
lle
d 
in
te
ri
m
 o
ut
co
m
es
) a
re
 s
te
ps
 
al
on
g 
th
e 
w
ay
 to
 th
e 
de
si
re
d 
en
d 
ou
tc
om
e.
 T
he
y 
ar
e 
of
te
n 
sm
al
le
r 
ch
an
ge
s 
th
at
 n
ee
d 
to
 h
ap
pe
n 
be
fo
re
 th
e 
fin
al
 d
es
ir
ed
 o
ut
co
m
e 
ca
n 
be
 re
ac
he
d.
Cr
os
s-
ag
en
cy
 o
ut
co
m
es
 a
re
 o
ut
co
m
es
 w
he
re
 th
e 
co
lle
ct
iv
e 
ef
fo
rt
 o
f 
m
or
e 
th
an
 o
ne
 g
ov
er
nm
en
t a
ge
nc
y 
or
 p
ro
gr
am
m
e 
is
 re
qu
ir
ed
 if
 th
e 
ou
tc
om
e 
is
 to
 b
e 
ac
hi
ev
ed
. 
Pr
oc
es
s 
ou
tc
om
es
 ty
pi
ca
lly
 m
ea
su
re
 th
e 
am
ou
nt
 o
f e
ff
or
t p
ut
 in
to
 a
 
pr
og
ra
m
m
e 
an
d 
th
e 
qu
al
it
y 
of
 th
e 
se
rv
ic
e 
pr
ov
id
ed
. T
he
y 
ca
n 
al
so
 
be
 a
pp
ro
pr
ia
te
 w
he
re
 it
 is
 im
po
rt
an
t t
o 
m
on
ito
r c
om
m
un
it
y 
su
pp
or
t 
fo
r a
 p
ro
gr
am
m
e.
  P
ro
ce
ss
 o
ut
co
m
es
 th
at
 m
ea
su
re
 e
ff
or
t c
an
 b
e 
ex
pr
es
se
d 
as
 o
ut
pu
ts
.
(S
ee
 P
ro
ce
ss
 o
ut
co
m
e 
m
on
to
r
ng
.)
H
ea
lt
h 
ou
tc
om
es
 s
ho
ul
d 
be
 e
xp
re
ss
ed
 in
 s
uc
h 
a 
w
ay
 th
at
 
in
di
ca
te
s 
th
e 
ty
pe
, d
ir
ec
ti
on
 a
nd
 e
xt
en
t o
f c
ha
ng
e 
in
 h
ea
lt
h 
kn
ow
le
dg
e,
 b
eh
av
io
ur
 o
r s
ta
tu
s 
so
ug
ht
 in
 a
n 
in
di
vi
du
al
 o
r 
po
pu
la
ti
on
 g
ro
up
.  
Ex
am
pl
e
• 
Ra
te
s 
of
 s
m
ok
in
g 
ce
ss
at
io
n 
in
 y
ou
ng
 w
om
en
 u
nd
er
 2
0 
ye
ar
s 
of
 
ag
e 
in
cr
ea
se
 b
y 
20
%
 a
t t
he
 e
nd
 o
f t
he
 p
ro
gr
am
m
e.
A
tt
ai
nm
en
t o
f t
he
 o
ut
co
m
es
 is
 m
ea
su
re
d 
th
ro
ug
h 
in
di
ca
to
rs
 (s
ee
 
In
d
ca
to
rs
).
 Id
ea
lly
, t
he
 h
ea
lt
h 
ou
tc
om
e 
so
ug
ht
 s
ho
ul
d 
be
 d
ir
ec
tl
y 
at
tr
ib
ut
ab
le
 to
 th
e 
in
te
rv
en
ti
on
, b
ut
 th
is
 is
 u
su
al
ly
 p
ro
bl
em
at
ic
 in
 
he
al
th
 p
ro
m
ot
io
n 
ac
ti
vi
ti
es
 (N
ut
be
am
 1
99
8)
. 
Th
is
 d
efi
ni
ti
on
 c
an
 b
e 
se
en
 a
s 
a 
sp
ec
ifi
c 
ap
pl
ic
at
io
n 
to
 p
ub
lic
 
he
al
th
 o
f t
he
 d
efi
ni
ti
on
 o
f a
n 
‘o
ut
co
m
e’
 p
ro
vi
de
d 
in
 th
e 
Pu
bl
ic
 
Fi
na
nc
e 
A
ct
 2
00
4 
(s
2(
1)
):
 ‘A
 s
ta
te
 o
r c
on
di
ti
on
 o
f s
oc
ie
ty
, t
he
 
ec
on
om
y 
or
 th
e 
en
vi
ro
nm
en
t a
nd
 in
cl
ud
es
 a
 c
ha
ng
e 
in
 th
at
 s
ta
te
 
or
 c
on
di
ti
on
.’ 
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Te
rm
D
efi
n
to
n
Ex
pl
an
at
or
y 
co
m
m
en
t a
nd
 e
xa
m
pl
e
Cr
os
s-
ag
en
cy
 o
ut
co
m
es
 s
ho
ul
d 
pr
ob
ab
ly
 b
e 
th
e 
ru
le
 ra
th
er
 th
an
 
th
e 
ex
ce
pt
io
n 
in
 c
om
pr
eh
en
si
ve
 p
ub
lic
 h
ea
lt
h 
pr
og
ra
m
m
es
. I
n 
su
ch
 s
itu
at
io
ns
, i
t i
s 
im
po
rt
an
t t
ha
t t
he
 ro
le
s 
an
d 
re
sp
on
si
bi
lit
ie
s 
of
 th
e 
pa
rt
ic
ip
at
in
g 
ag
en
ci
es
 a
re
 a
gr
ee
d 
–
 in
cl
ud
in
g 
w
ho
 is
 
re
sp
on
si
bl
e 
fo
r m
on
ito
ri
ng
 o
ut
co
m
es
 –
 b
ef
or
e 
th
e 
pr
og
ra
m
m
e 
be
gi
ns
.
O
ut
co
m
es
 
m
on
to
r
ng
A
 p
la
n 
fo
r t
he
 ro
ut
in
e,
 s
ys
te
m
at
ic
 c
ol
le
ct
io
n 
an
d 
re
co
rd
in
g 
of
 
in
fo
rm
at
io
n 
ab
ou
t a
sp
ec
ts
 o
f a
 p
ro
gr
am
m
e 
ov
er
 ti
m
e.
 T
he
 p
ur
po
se
 
is
 to
 a
ss
es
s 
w
he
th
er
 p
ro
gr
es
s 
is
 b
ei
ng
 m
ad
e 
on
 a
ch
ie
vi
ng
 th
e 
pr
og
ra
m
m
e 
ob
je
ct
iv
es
.
Pr
ep
ar
in
g 
th
e 
ou
tc
om
es
 m
on
ito
ri
ng
 p
la
n 
re
qu
ir
es
 a
ss
es
si
ng
:
• 
w
ha
t n
ee
ds
 to
 b
e 
m
ea
su
re
d 
to
 d
em
on
st
ra
te
 s
uc
ce
ss
• 
ho
w
 th
in
gs
 a
re
 g
oi
ng
 to
 b
e 
m
ea
su
re
d 
an
d 
by
 w
ho
m
 (d
ec
id
in
g 
w
ha
t i
nd
ic
at
or
s 
ar
e 
go
in
g 
to
 b
e 
us
ed
, a
ft
er
 c
on
si
de
ri
ng
 
is
su
es
 s
uc
h 
as
 v
al
id
it
y,
 re
lia
bi
lit
y,
 s
en
si
ti
vi
ty
, a
tt
ri
bu
ti
on
 a
nd
 
fe
as
ib
ili
ty
) (
se
e 
In
d
ca
to
rs
.)
• 
 
th
e 
ti
m
ef
ra
m
es
 fo
r d
el
iv
er
in
g 
in
fo
rm
at
io
n 
ab
ou
t t
he
 
pe
rf
or
m
an
ce
 o
f t
he
 p
ro
gr
am
m
e 
ag
ai
ns
t t
he
 s
ta
te
d 
ob
je
ct
iv
es
 
to
 d
ec
is
io
n-
m
ak
er
s 
an
d 
ke
y 
st
ak
eh
ol
de
rs
 in
 a
 ti
m
el
y 
m
an
ne
r.
O
ut
co
m
es
 m
on
ito
ri
ng
 m
ay
 o
r m
ay
 n
ot
 in
cl
ud
e 
a 
fo
rm
al
 e
va
lu
at
io
n 
pr
oc
es
s 
de
pe
nd
in
g 
on
 th
e 
ob
je
ct
iv
es
 o
f t
he
 p
ro
gr
am
m
e.
 (S
ee
 
Ev
al
ua
to
n.
)
O
ut
pu
ts
O
ut
pu
ts
 a
re
 th
in
gs
 (e
g,
 g
oo
ds
) p
ro
du
ce
d,
 s
er
vi
ce
s 
de
liv
er
ed
, 
ev
en
ts
 h
el
d,
 o
r p
ar
ti
ci
pa
ti
on
 g
en
er
at
ed
 re
su
lt
in
g 
fr
om
 th
e 
ac
ti
vi
ti
es
 
un
de
rt
ak
en
.  
(S
ee
 O
ut
co
m
es
 a
nd
 P
ro
ce
ss
 o
ut
co
m
e 
m
on
to
r
ng
).
Th
is
 d
efi
ni
ti
on
 is
 c
on
si
st
en
t w
it
h 
th
at
 p
ro
vi
de
d 
in
 th
e 
Pu
bl
ic
 
Fi
na
nc
e 
A
ct
 2
00
4.
  C
om
m
on
 p
ub
lic
 h
ea
lt
h 
ou
tp
ut
s 
ar
e 
th
in
gs
 s
uc
h 
as
 in
fo
rm
at
io
n 
se
rv
ic
es
 p
ro
vi
de
d,
 m
ee
ti
ng
s 
he
ld
 o
r a
tt
en
de
d,
 
an
d 
ed
uc
at
io
na
l/
tr
ai
ni
ng
 o
r s
oc
ia
l m
ar
ke
ti
ng
 p
ro
du
ct
s 
or
 s
er
vi
ce
s 
de
liv
er
ed
. S
uc
h 
ou
tp
ut
s 
ar
e 
in
te
nd
ed
 to
 h
av
e 
an
 im
pa
ct
 th
at
 
as
si
st
s 
or
 re
su
lt
s 
in
 a
ch
ie
vi
ng
 th
e 
de
si
re
d 
pu
bl
ic
 h
ea
lt
h 
ou
tc
om
e,
 
su
ch
 a
s 
a 
ch
an
ge
 in
 h
ea
lt
h 
kn
ow
le
dg
e 
an
d 
be
ha
vi
ou
r.
 
(S
ee
 O
ut
co
m
es
 a
nd
 P
ro
ce
ss
 o
ut
co
m
e 
m
on
to
r
ng
.)
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Te
rm
D
efi
n
to
n
Ex
pl
an
at
or
y 
co
m
m
en
t a
nd
 e
xa
m
pl
e
Pr
oc
es
s 
ou
tc
om
e 
m
on
to
r
ng
Th
is
 is
 li
ke
 o
ut
co
m
e 
m
on
ito
ri
ng
 b
ut
 in
cl
ud
es
 k
ee
pi
ng
 tr
ac
k 
of
 h
ow
 
w
el
l a
 p
ro
gr
am
m
e 
is
 b
ei
ng
 im
pl
em
en
te
d 
in
 it
s 
di
ff
er
en
t a
sp
ec
ts
.  
Pr
oc
es
s 
ou
tc
om
e 
m
on
ito
ri
ng
 p
ro
vi
de
s 
th
e 
ba
si
s 
fo
r p
ro
gr
am
m
e 
st
af
f 
to
 a
ss
ur
e 
th
em
se
lv
es
 th
at
 g
oo
d 
ou
tc
om
es
 a
re
 a
ss
oc
ia
te
d 
w
it
h 
go
od
 
pr
og
ra
m
m
e 
de
liv
er
y.
  I
f t
he
 d
es
ir
ed
 o
ut
co
m
es
 a
re
 n
ot
 a
ch
ie
ve
d,
 th
en
 
th
e 
ag
en
cy
 w
ill
 h
av
e 
su
ffi
ci
en
t i
nf
or
m
at
io
n 
to
 a
ss
es
s 
w
hi
ch
 a
sp
ec
ts
 
of
 p
ro
gr
am
m
e 
de
liv
er
y 
ne
ed
 to
 b
e 
de
ve
lo
pe
d 
or
 c
ha
ng
ed
. 
(S
ee
 a
ls
o 
Ba
la
nc
ed
 s
co
re
ca
rd
.)
A
 p
ro
gr
am
m
e 
th
eo
ry
 o
f c
ha
ng
e 
w
ill
 in
di
ca
te
 w
ha
t k
in
ds
 o
f i
np
ut
s 
an
d 
pr
oc
es
se
s 
ar
e 
lik
el
y 
to
 p
ro
du
ce
 a
 p
re
ve
nt
io
n 
ef
fe
ct
. F
or
 
ex
am
pl
e,
 a
 h
om
e-
vi
si
ti
ng
 p
ro
gr
am
m
e 
m
ig
ht
 d
et
ai
l t
he
 fo
llo
w
in
g 
as
 v
ita
l t
o 
go
od
 c
lie
nt
 o
ut
co
m
es
:
• 
ap
pr
op
ri
at
el
y 
ex
pe
ri
en
ce
d,
 s
ki
lle
d 
an
d 
su
pe
rv
is
ed
 s
ta
ff
• 
st
af
f w
ho
 a
re
 e
m
pa
th
et
ic
 a
nd
 w
ar
m
 in
 th
ei
r i
nt
er
ac
ti
on
s 
• 
a 
fa
m
ily
/w
ha¯
na
u 
as
se
ss
m
en
t t
ha
t i
de
nt
ifi
es
 s
tr
en
gt
hs
 a
nd
 
ch
al
le
ng
es
 li
ke
ly
 to
 h
el
p 
or
 h
in
de
r c
hi
ld
-r
ea
ri
ng
 (e
g,
 in
cl
ud
es
 a
 
sc
re
en
 fo
r f
am
ily
 v
io
le
nc
e,
 s
ub
st
an
ce
 a
bu
se
, d
ep
re
ss
io
n)
• 
th
e 
as
se
ss
m
en
t p
ro
ce
ss
 e
nc
ou
ra
ge
s 
co
-o
pe
ra
ti
on
 a
nd
 re
du
ce
s 
de
fe
ns
iv
en
es
s
• 
fa
m
ili
es
 a
re
 v
is
ite
d 
at
 s
uf
fic
ie
nt
ly
 re
gu
la
r i
nt
er
va
ls
• 
id
ea
lly
 th
e 
et
hn
ic
it
y 
of
 w
or
ke
rs
 a
nd
 p
ri
m
ar
y 
ca
re
gi
ve
rs
 a
re
 
m
at
ch
ed
 to
 m
ax
im
is
e 
en
ga
ge
m
en
t 
• 
th
er
e 
is
 a
 d
ev
el
op
m
en
ta
l m
od
el
 to
 c
om
pa
re
 c
hi
ld
re
n’
s 
pr
og
re
ss
 a
ga
in
st
 
• 
th
e 
de
ve
lo
pm
en
ta
l m
od
el
 is
 e
as
y 
to
 c
om
m
un
ic
at
e 
to
 
ca
re
gi
ve
rs
 a
nd
 th
ey
 ‘b
uy
’ i
t
• 
de
ve
lo
pm
en
ta
l o
ut
co
m
es
 fo
r c
hi
ld
re
n 
an
d 
co
nd
it
io
ns
 th
at
 
hi
nd
er
 n
or
m
al
 d
ev
el
op
m
en
t a
re
 s
ys
te
m
at
ic
al
ly
 tr
ac
ke
d
• 
gu
id
an
ce
 is
 p
ro
vi
de
d 
in
 a
 re
sp
on
si
ve
 w
ay
 (i
e,
 is
 ti
m
el
y,
 
so
lu
ti
on
 fo
cu
se
d,
 re
al
is
ti
c 
an
d 
ch
ec
ke
d 
fo
r u
nd
er
st
an
di
ng
) 
• 
go
al
-s
et
ti
ng
 is
 u
se
d 
to
 e
nh
an
ce
 c
ar
eg
iv
er
 m
ot
iv
at
io
n 
an
d 
to
 
pr
io
ri
tis
e 
ac
ti
on
s.
Re
gu
la
r s
up
er
vi
si
on
 m
ee
ti
ng
s 
an
d/
or
 p
ro
gr
am
m
e 
re
vi
ew
s 
pr
ov
id
e 
sp
ac
e 
fo
r c
lie
nt
s’
 p
ro
gr
es
s 
to
 b
e 
ch
ec
ke
d 
ag
ai
ns
t t
he
 q
ua
lit
y 
of
 
pr
og
ra
m
m
e 
de
liv
er
y.
 A
ny
 c
ha
ng
es
 in
 c
lie
nt
 p
la
ns
, p
ro
gr
am
m
e 
de
si
gn
 o
r p
ro
fe
ss
io
na
l d
ev
el
op
m
en
t c
an
 b
e 
co
ns
id
er
ed
 a
 p
ro
ce
ss
 
ou
tc
om
e.
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Te
rm
D
efi
n
to
n
Ex
pl
an
at
or
y 
co
m
m
en
t a
nd
 e
xa
m
pl
e
Pu
bl
c
 h
ea
lth
 
 
Po
pu
la
to
n-
ba
se
d 
  
 
pu
bl
c
 h
ea
lth
 
Pu
bl
c
 h
ea
lth
 
ac
to
n
Th
er
e 
is
 a
 ra
ng
e 
of
 te
rm
s 
an
d 
de
fin
it
io
ns
 re
la
ti
ng
 to
 p
ub
lic
 h
ea
lt
h,
 
in
cl
ud
in
g 
pu
bl
ic
 h
ea
lt
h 
ac
ti
on
 a
nd
 p
op
ul
at
io
n-
ba
se
d 
pu
bl
ic
 h
ea
lt
h.
 
Th
e 
W
or
ld
 H
ea
lt
h 
O
rg
an
iz
at
io
n 
(1
99
8)
 d
efi
ne
s 
pu
bl
ic
 h
ea
lt
h 
as
: 
 
Th
e 
sc
ie
nc
e 
an
d 
ar
t o
f p
ro
m
ot
in
g 
he
al
th
, p
re
ve
nt
in
g 
di
se
as
e,
 a
nd
 
pr
ol
on
gi
ng
 li
fe
 th
ro
ug
h 
th
e 
or
ga
ni
ze
d 
ef
fo
rt
s 
of
 s
oc
ie
ty
.
It 
ca
n 
be
 a
rg
ue
d 
th
at
 th
is
 d
efi
ni
ti
on
 o
m
it
s 
th
e 
im
po
rt
an
t p
oi
nt
 th
at
 
pu
bl
ic
 h
ea
lt
h 
pr
im
ar
ily
 fo
cu
se
s 
on
 th
e 
he
al
th
 o
f t
he
 p
op
ul
at
io
n 
or
 
po
pu
la
ti
on
 s
ub
-g
ro
up
s 
an
d 
no
t t
he
 h
ea
lt
h 
of
 s
pe
ci
fic
 in
di
vi
du
al
s.
  
Th
is
 fo
cu
s 
on
 p
op
ul
at
io
ns
 in
 p
ub
lic
 h
ea
lt
h 
is
 id
en
ti
fie
d 
m
or
e 
ex
pl
ic
it
ly
 in
 m
or
e 
re
ce
nt
 d
efi
ni
ti
on
s.
• 
‘P
ub
lic
 h
ea
lt
h 
is
 c
on
ce
rn
ed
 w
it
h 
im
pr
ov
in
g 
th
e 
he
al
th
 o
f t
he
 
po
pu
la
ti
on
, r
at
he
r t
ha
n 
tr
ea
ti
ng
 th
e 
di
se
as
es
 o
f i
nd
iv
id
ua
l 
pa
ti
en
ts
’  
(D
ep
ar
tm
en
t o
f H
ea
lt
h 
20
04
 c
ite
d 
in
 P
ub
lic
 H
ea
lt
h 
el
ec
tr
on
ic
 L
ib
ra
ry
 ).
• 
‘[P
ub
lic
 h
ea
lt
h 
is
] c
on
ce
rn
ed
 w
it
h 
th
e 
he
al
th
 o
f t
he
 c
om
m
un
it
y 
as
 a
 w
ho
le
’ (
Am
er
ic
an
 Jo
ur
na
l o
f P
ub
lic
 H
ea
lth
 2
00
6,
 w
eb
si
te
 
(h
tt
p:
//
w
w
w
.a
jp
h.
or
g/
))
.
• 
Pu
bl
ic
 h
ea
lt
h 
ac
ti
on
 is
  ‘
Co
lle
ct
iv
e 
ac
ti
on
 fo
r s
us
ta
in
ed
 
po
pu
la
ti
on
-w
id
e 
he
al
th
 im
pr
ov
em
en
t …
 a
nd
 to
 re
du
ce
 h
ea
lt
h 
in
eq
ua
lit
ie
s.
 R
es
po
ns
ib
ili
ty
 fo
r s
uc
h 
ac
ti
on
 is
 n
ot
 c
on
fin
ed
 
to
 th
e 
he
al
th
 s
ec
to
r b
ut
 s
ho
ul
d 
in
cl
ud
e 
al
l s
ec
to
rs
 w
ho
se
 
ac
ti
on
s 
af
fe
ct
 th
e 
he
al
th
 o
f p
op
ul
at
io
ns
. P
op
ul
at
io
ns
 c
an
 
be
 g
eo
gr
ap
hi
c 
an
d/
or
 d
efi
ne
d 
by
 fa
ct
or
s 
su
ch
 a
s 
et
hn
ic
it
y,
 
ge
nd
er
, a
ge
, s
ex
ua
l o
ri
en
ta
ti
on
, i
nc
om
e 
et
c.
’ (
B
ea
gl
eh
ol
e 
et
 a
l 
20
04
; P
ub
lic
 H
ea
lt
h 
A
dv
is
or
y 
Co
m
m
it
te
e 
20
06
).
• 
‘P
ub
lic
 h
ea
lt
h 
is
 th
e 
or
ga
ni
se
d 
re
sp
on
se
 b
y 
so
ci
et
y 
to
 p
ro
te
ct
 
an
d 
pr
om
ot
e 
he
al
th
, a
nd
 to
 p
re
ve
nt
 il
ln
es
s,
 in
ju
ry
 a
nd
 
di
sa
bi
lit
y.
 T
he
 s
ta
rt
in
g 
po
in
t f
or
 id
en
ti
fy
in
g 
pu
bl
ic
 h
ea
lt
h 
is
su
es
, p
ro
bl
em
s 
an
d 
pr
io
ri
ti
es
, a
nd
 fo
r d
es
ig
ni
ng
 a
nd
 
im
pl
em
en
ti
ng
 in
te
rv
en
ti
on
s,
 is
 th
e 
po
pu
la
ti
on
 a
s 
a 
w
ho
le
, o
r 
po
pu
la
ti
on
 s
ub
-g
ro
up
s.
’ (
N
at
io
na
l P
ub
lic
 H
ea
lt
h 
Pa
rt
ne
rs
hi
p 
20
06
).
(S
ee
 a
ls
o 
Ev
d
en
ce
-b
as
ed
 p
ub
lc
 h
ea
lth
.)
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Te
rm
D
efi
n
to
n
Ex
pl
an
at
or
y 
co
m
m
en
t a
nd
 e
xa
m
pl
e
Re
la
b
lt
y
Re
lia
bi
lit
y 
is
 th
e 
ex
te
nt
 to
 w
hi
ch
 a
 m
ea
su
re
, w
he
n 
us
ed
 re
pe
at
ed
ly
 in
 
th
e 
sa
m
e 
w
ay
, w
ill
 p
ro
du
ce
 th
e 
sa
m
e 
or
 a
 s
im
ila
r r
es
ul
t.
  
Fo
r e
xa
m
pl
e,
 if
 w
e 
w
er
e 
in
te
re
st
ed
 in
 m
on
ito
ri
ng
 a
 p
er
so
n’
s 
w
ei
gh
t a
nd
 u
se
d 
a 
ch
ea
p 
w
ei
gh
in
g 
m
ac
hi
ne
 th
at
 p
ro
du
ce
d 
a 
di
ff
er
en
t r
ea
di
ng
 e
ac
h 
ti
m
e 
it 
w
as
 u
se
d 
(w
he
n 
al
l o
th
er
 fa
ct
or
s 
w
er
e 
th
e 
sa
m
e)
, t
he
n 
th
e 
m
ac
hi
ne
 w
ou
ld
 n
ot
 b
e 
a 
re
lia
bl
e 
in
st
ru
m
en
t t
o 
us
e.
Ro
bu
st
ne
ss
 to
 
w
th
st
an
d 
sc
ru
tn
y
It 
is
 im
po
rt
an
t t
ha
t a
ss
es
sm
en
ts
 a
bo
ut
 th
e 
ef
fe
ct
iv
en
es
s 
of
 p
ub
lic
 
he
al
th
 p
ro
gr
am
m
es
 fu
nd
ed
 b
y 
go
ve
rn
m
en
t m
on
ey
 b
e 
ab
le
 to
 
w
it
hs
ta
nd
 s
cr
ut
in
y 
by
 a
ll 
th
e 
st
ak
eh
ol
de
rs
 a
nd
 o
th
er
 in
te
re
st
ed
 
pa
rt
ie
s.
 
W
e 
re
co
m
m
en
d 
th
at
 fo
r m
os
t p
ub
lic
 h
ea
lt
h 
pr
og
ra
m
m
es
 it
 is
 
ad
vi
sa
bl
e 
th
at
 a
 p
ro
gr
am
m
e’
s 
su
cc
es
s 
no
t b
e 
at
tr
ib
ut
ed
 to
 a
 
si
ng
le
 c
ri
te
ri
on
: r
ob
us
tn
es
s 
is
 p
ro
vi
de
d 
by
 th
e 
to
ta
lit
y 
of
 th
e 
ou
tc
om
e 
m
on
ito
ri
ng
 re
gi
m
e.
  
Se
ns
t
v
ty
S
en
si
ti
vi
ty
 re
fe
rs
 to
 h
ow
 w
el
l a
 m
ea
su
re
 is
 a
bl
e 
to
 a
cc
ur
at
el
y 
de
te
ct
 
w
he
n 
a 
ch
an
ge
 h
as
 o
cc
ur
re
d 
in
 th
e 
ou
tc
om
e 
be
in
g 
m
on
ito
re
d.
 
 
Fo
r e
xa
m
pl
e,
 a
 w
ei
gh
in
g 
m
ac
hi
ne
 th
at
 w
as
 a
bl
e 
to
 d
iff
er
en
tia
te
 a
 
ch
an
ge
 in
 w
ei
gh
t b
y 
10
0 
gr
am
 g
ra
du
at
io
ns
 is
 m
or
e 
se
ns
it
iv
e 
th
an
 
a 
m
ac
hi
ne
 th
at
 c
ou
ld
 o
nl
y 
de
te
ct
 c
ha
ng
es
 in
 5
00
 g
ra
m
 g
ra
da
ti
on
s.
Ta
rg
et
A
 ta
rg
et
 is
 th
e 
am
ou
nt
 o
f c
ha
ng
e 
de
si
re
d,
 o
r e
xp
ec
te
d,
 in
 a
 s
pe
ci
fic
 
ti
m
e 
pe
ri
od
 th
ro
ug
h 
th
e 
im
pl
em
en
ta
ti
on
 o
f t
he
 h
ea
lt
h 
pr
og
ra
m
m
e.
 
Ta
rg
et
s 
sh
ou
ld
 b
e 
ba
se
d 
on
 s
pe
ci
fic
 a
nd
 m
ea
su
ra
bl
e 
ch
an
ge
s 
in
 h
ea
lt
h 
ou
tc
om
es
. S
et
ti
ng
 ta
rg
et
s 
he
lp
s 
de
fin
e 
th
e 
pr
oc
es
s 
to
w
ar
ds
 a
ch
ie
vi
ng
 th
e 
he
al
th
 o
bj
ec
ti
ve
 s
et
, a
lt
ho
ug
h 
ta
rg
et
s 
re
qu
ir
e 
th
e 
ex
is
te
nc
e 
of
 a
n 
ap
pr
op
ri
at
e 
in
di
ca
to
r (
N
ut
be
am
 1
99
8)
.
(S
ee
 In
d
ca
to
rs
.)
Th
eo
ry
 o
f c
ha
ng
e/
ac
to
n
A
 th
eo
ry
 o
f c
ha
ng
e/
ac
ti
on
 is
 a
 s
ta
te
m
en
t a
bo
ut
 h
ow
 p
ra
ct
it
io
ne
rs
 
be
lie
ve
 in
di
vi
du
al
, i
nt
er
-g
ro
up
 a
nd
 s
oc
ia
l/
 s
ys
te
m
ic
 c
ha
ng
e 
ha
pp
en
s,
 a
nd
 h
ow
 th
e 
pr
op
os
ed
 a
ct
io
ns
 w
ill
 p
ro
du
ce
 p
os
it
iv
e 
re
su
lt
s.
 A
 g
oo
d 
th
eo
ry
 o
f c
ha
ng
e 
ex
pl
ic
it
ly
 d
es
cr
ib
es
 th
e 
as
su
m
pt
io
ns
 a
nd
 c
au
sa
l l
in
ks
 th
ou
gh
t t
o 
be
 im
po
rt
an
t f
or
 a
ch
ie
vi
ng
 
th
e 
he
al
th
 o
ut
co
m
e 
so
ug
ht
.
W
he
re
 in
it
ia
l e
vi
de
nc
e 
fo
r t
he
 e
ff
ec
ti
ve
ne
ss
 o
f a
n 
in
te
rv
en
ti
on
 
is
 la
ck
in
g,
 a
 ro
bu
st
 th
eo
ry
 o
f c
ha
ng
e 
sh
ou
ld
 b
e 
ar
ti
cu
la
te
d 
to
 
ju
st
if
y 
th
e 
ch
oi
ce
 o
f i
nt
er
ve
nt
io
n.
 U
se
d 
in
 th
is
 w
ay
, a
 th
eo
ry
 o
f 
ch
an
ge
 p
ro
vi
de
s 
th
e 
‘lo
gi
c 
m
od
el
’ f
ra
m
ew
or
k 
to
 p
la
n 
an
d 
ju
st
if
y 
th
e 
in
te
rv
en
ti
on
 s
el
ec
te
d.
  A
 th
eo
ry
 o
f c
ha
ng
e 
ap
pr
oa
ch
 m
ay
 b
e 
pa
rt
ic
ul
ar
ly
 a
pp
ro
pr
ia
te
 w
he
n 
in
te
rv
en
ti
on
s 
ar
e 
ai
m
ed
 a
t m
in
or
it
y 
po
pu
la
ti
on
 g
ro
up
s.
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Te
rm
D
efi
n
to
n
Ex
pl
an
at
or
y 
co
m
m
en
t a
nd
 e
xa
m
pl
e
T
m
el
y 
da
ta
/
n
fo
rm
at
o
n
In
fo
rm
at
io
n 
is
 ti
m
el
y 
w
he
n 
it 
co
nt
ai
ns
 d
at
a 
di
re
ct
ly
 re
le
va
nt
 to
 th
e 
pr
og
ra
m
m
e 
an
d 
–
 im
po
rt
an
tl
y 
–
 a
va
ila
bl
e 
in
 a
 ti
m
e 
fr
am
e 
w
he
re
 
it 
ca
n 
us
ef
ul
ly
 in
fo
rm
 d
ec
is
io
ns
 a
bo
ut
 w
he
th
er
 th
e 
pr
og
ra
m
m
e 
is
 
pe
rf
or
m
in
g 
as
 p
la
nn
ed
 a
nd
 w
ha
t t
hi
ng
s 
ne
ed
 to
 b
e 
ch
an
ge
d 
to
 
im
pr
ov
e 
th
e 
pe
rf
or
m
an
ce
 o
f t
he
 p
ro
gr
am
m
e,
 if
 re
qu
ir
ed
. 
S
om
e 
na
ti
on
al
 d
at
a 
se
ts
 a
re
 s
ch
ed
ul
ed
 to
 b
e 
co
lle
ct
ed
 o
n 
5-
ye
ar
ly
 d
at
a.
 S
uc
h 
da
ta
 is
 u
nl
ik
el
y 
to
 b
e 
ti
m
el
y 
fo
r p
er
fo
rm
an
ce
 
m
on
ito
ri
ng
 p
ur
po
se
s 
if 
th
e 
pr
og
ra
m
m
e 
w
ill
 o
nl
y 
ru
n 
fo
r 3
 y
ea
rs
, 
sa
y.
  S
im
ila
rl
y,
 n
at
io
na
l m
or
ta
lit
y 
an
d 
m
or
bi
di
ty
 d
at
a 
is
 ty
pi
ca
lly
 
on
ly
 a
va
ila
bl
e 
18
 to
 2
4 
m
on
th
s 
af
te
r t
he
 e
ve
nt
. S
uc
h 
in
fo
rm
at
io
n 
m
ay
 n
ot
 b
e 
ti
m
el
y 
fo
r s
om
e 
pr
og
ra
m
m
es
, a
lt
ho
ug
h 
lo
ca
l d
at
a 
m
ay
 
be
 a
va
ila
bl
e 
w
it
hi
n 
a 
m
or
e 
us
ef
ul
 ti
m
e 
fr
am
e.
 
T
m
n
g
Ti
m
in
g 
re
fe
rs
 to
 th
e 
ti
m
e 
pe
ri
od
 b
et
w
ee
n 
w
he
n 
an
 a
ct
iv
it
y 
to
ok
 p
la
ce
 
an
d 
w
he
n 
a 
ch
an
ge
 in
 th
e 
de
si
re
d 
ou
tc
om
e 
w
as
 o
bs
er
ve
d.
 
Ti
m
in
g 
is
 a
n 
im
po
rt
an
t a
sp
ec
t i
n 
es
ta
bl
is
hi
ng
 ‘a
tt
ri
bu
ti
on
’, 
an
d 
be
in
g 
ab
le
 to
 m
on
ito
r w
he
th
er
 a
 p
ro
gr
am
m
e 
is
 w
or
ki
ng
.
Va
ld
ty
Va
lid
it
y 
re
fe
rs
 to
 h
ow
 w
el
l a
 p
ro
po
se
d 
in
st
ru
m
en
t m
ea
su
re
s 
th
e 
ou
tc
om
e 
of
 in
te
re
st
. S
om
e 
ou
tc
om
es
 m
ay
 b
e 
m
ea
su
re
d 
di
re
ct
ly
, 
w
hi
le
 o
th
er
s 
w
ill
 re
qu
ir
e 
a 
pr
ox
y 
m
et
ho
d 
th
at
 re
su
lt
s 
in
 a
 p
ro
xy
 
m
ea
su
re
. G
en
er
al
ly
, t
he
 m
or
e 
di
re
ct
 a
 m
ea
su
re
 is
, t
he
 m
or
e 
va
lid
 it
 is
 
lik
el
y 
to
 b
e.
 
Th
er
e 
is
 o
ft
en
 m
or
e 
th
an
 o
ne
 w
ay
 o
f m
ea
su
ri
ng
 a
n 
ou
tc
om
e 
of
 
in
te
re
st
, a
nd
 th
er
e 
ca
n 
be
 c
on
si
de
ra
bl
e 
de
ba
te
 a
bo
ut
 h
ow
 ‘v
al
id
’ a
 
m
ea
su
re
 a
ct
ua
lly
 is
. 
Fo
r e
xa
m
pl
e,
 th
e 
be
st
 w
ay
 to
 m
ea
su
re
 b
od
y 
co
m
po
si
ti
on
 
(p
ar
ti
cu
la
rl
y 
le
an
 a
nd
 fa
t m
as
s)
 is
 u
nd
er
-w
at
er
 d
en
si
to
m
et
ry
 
(w
ei
gh
in
g)
, b
ut
 th
is
 is
 n
ot
 p
ra
ct
ic
al
 o
ut
si
de
 s
m
al
l c
lin
ic
al
 s
tu
di
es
. 
Th
er
ef
or
e,
 m
ea
su
re
s 
of
 w
ei
gh
t a
dj
us
te
d 
fo
r h
ei
gh
t (
eg
, b
od
y 
m
as
s 
in
de
x,
 B
M
I)
 a
re
 o
ft
en
 u
se
d 
to
 re
fle
ct
 b
od
y 
co
m
po
si
ti
on
, 
pa
rt
ic
ul
ar
ly
 b
od
y 
fa
t m
as
s.
 A
lt
ho
ug
h 
B
M
I i
s 
co
rr
el
at
ed
 w
it
h 
bo
dy
 
fa
t m
as
s,
 th
is
 re
la
ti
on
sh
ip
 v
ar
ie
s 
ac
co
rd
in
g 
to
 b
od
y 
bu
ild
, a
ge
 
an
d 
et
hn
ic
it
y.
 T
he
re
fo
re
, B
M
I i
s 
no
t r
ec
om
m
en
de
d 
fo
r a
ss
es
si
ng
 
ex
ce
ss
 b
od
y 
fa
t m
as
s 
(o
be
si
ty
) a
t a
n 
in
di
vi
du
al
 le
ve
l.
H
ow
ev
er
, B
M
I c
an
 b
e 
us
ef
ul
 fo
r a
ss
es
si
ng
 o
be
si
ty
 a
t a
 p
op
ul
at
io
n 
le
ve
l i
f u
se
d 
an
d 
in
te
rp
re
te
d 
ap
pr
op
ri
at
el
y.
 B
M
I b
as
ed
 o
n 
di
re
ct
 
m
ea
su
re
m
en
t o
f h
ei
gh
t a
nd
 w
ei
gh
t i
s 
m
or
e 
va
lid
 th
an
 B
M
I b
as
ed
 
on
 s
el
f-
re
po
rt
ed
 h
ei
gh
t a
nd
 w
ei
gh
t,
 p
ar
ti
cu
la
rl
y 
if 
m
ea
su
re
m
en
ts
 
ar
e 
ta
ke
n 
by
 tr
ai
ne
d 
ob
se
rv
er
s 
us
in
g 
ap
pr
op
ri
at
e 
eq
ui
pm
en
t a
nd
 
st
an
da
rd
is
ed
 p
ro
ce
du
re
s.
U
lt
im
at
el
y,
 th
e 
ch
oi
ce
 o
f m
ea
su
re
 fo
r a
 p
ar
ti
cu
la
r p
ro
gr
am
m
e 
w
ill
 
de
pe
nd
 o
n 
a 
nu
m
be
r o
f f
ac
to
rs
, i
nc
lu
di
ng
 v
al
id
it
y 
an
d 
pr
ac
ti
ca
lit
y.
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